Deep Learning Based Analysis of Prostate Cancer from MP-MRI by Carneiro Neto, Pedro
Master’s Programme in Computer, Communication and Information Sciences
Deep Learning Based
Analysis of Prostate Cancer
from MP-MRI
Classification, detection and segmentation of prostate cancer lesions
from MP-MRI with deep learning based methods
Pedro David Carneiro Neto
MASTER’S
THESIS
Aalto University
MASTER’S THESIS 2020
Deep Learning Based Analysis of Prostate
Cancer from MP-MRI
Classification, detection and segmentation of prostate
cancer lesions from MP-MRI with deep learning
based methods
Pedro David Carneiro Neto
Thesis submitted in partial fulfillment of the requirements for
the degree of Master of Science in Technology.
Otaniemi, 25 May 2020
Supervisor: professor Juho Kannala
Advisor 1: doctor Saad Ullah Akram
Advisor 2: doctor Harri Merisaari
Advisor 3: medical doctor Ivan Jambor
Aalto University
School of Science
Master’s Programme in Computer,
Communication and Information Sciences
Abstract
Aalto University, P.O. Box 11000, FI-00076 Aalto www.aalto.fi
Author
Pedro David Carneiro Neto
Title
Deep Learning Based Analysis of Prostate Cancer from MP-MRI
School School of Science
Master’s programme Computer, Communication and Information Sciences
Major Computer Science - Big Data and Large-Scale Computing Code SCI3042
Supervisor professor Juho Kannala
Advisor doctor Saad Ullah Akram; doctor Harri Merisaari; medical doctor Ivan Jambor
Level Master’s thesis Date 25 May 2020 Pages 74+4 Language English
Abstract
The diagnosis of prostate cancer faces a problem with overdiagnosis that leads to
damaging side effects due to unnecessary treatment. Research has shown that the use
of multi-parametric magnetic resonance images to conduct biopsies can drastically help
to mitigate the overdiagnosis, thus reducing the side effects on healthy patients. This
study aims to investigate the use of deep learning techniques to explore computer-aid
diagnosis based on MRI as input. Several diagnosis problems ranging from classification
of lesions as being clinically significant or not to the detection and segmentation of lesions
are addressed with deep learning based approaches.
This thesis tackled two main problems regarding the diagnosis of prostate cancer. Firstly,
a deep neural network architecture, XmasNet, was used to conduct two large experiments
on the classification of lesions. Secondly, detection and segmentation experiments were
conducted, first on the prostate and afterward on the prostate cancer lesions. The for-
mer experiments explored the lesions through a two-dimensional space, while the latter
explored models to work with three-dimensional inputs. For this task, the 3D models
explored were the 3D U-Net and a pretrained 3D ResNet-18. A rigorous analysis of all
these problems was conducted with a total of two networks, two cropping techniques, two
resampling techniques, two crop sizes, five input sizes and data augmentations experi-
mented for lesion classification. While for segmentation two models, two input sizes and
data augmentations were experimented. Moreover the experiments were conducted for
both sequences independently, and within the lesion classification problem, the experi-
ments were also conducted for both sequences simultaneously. However, while the binary
classification of the clinical significance of lesions and the detection and segmentation of
the prostate already achieve the desired results (0.870 AUC and 0.915 dice score respec-
tively), the classification of the PIRADS score and the segmentation of lesions still have a
large margin to improve (0.664 accuracy and 0.690 dice score respectively). It was also
studied how some flaws in the dataset can be addressed to improve the results of all these
problems. Further research on the problem is still needed, but nonetheless, this thesis
established sufficient ground for future work to be conducted.
Keywords deep learning, computer vision , prostate cancer, segmentation, classification,
computer-aided diagnosis systems
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1. Introduction
Prostate cancer is one of the biggest causes of cancer deaths in men around
the world. It has also been consistently ranked as one of the most frequent
cancers to be diagnosed in men by a myriad of organizations worldwide,
with 84 different countries having it as the most diagnosed cancer in
men [1]. Predictions for 2020 indicate that the number of new cases
in the United States will be around 191,930, and 33,330 deaths caused
by the disease [2]. The disease’s risk varies with some factors like the
race, medical records of the family, age and daily diet choices [1], and it
only affects men since the prostate is a gland that belongs to the male
reproductive system [3]. Regarding these factors, it has been shown that
the disease is not only more likely to be diagnosed in black men, but it also
shows higher mortality rates [4]. Nevertheless, family medical record is
still rather important because having a first-degree relative with prostate
cancer doubles the chances of an individual to be also affected in the future
[5]. Although responsible for enormous fatalities every year, it does not
have a high mortality rate, especially if it is detected in early stages. Hence,
the detection in these stages can prevent death and avoid other treatments,
with respective side effects and harms, especially if the disease spreads to
other body parts.
It is estimated that two-thirds of the affected patients do not show any
symptoms [6]. Frequently, the initial phase of the diagnosis is the screening
phase that can be performed through two exam. The first example exam is
the measurement of the prostate-specific antigen (PSA), that uses blood
tests to detect the levels of the antigen. If they are high, there is a chance
of prostate cancer, even though the values may change with other diseases.
Thus, it does not guarantee the presence of cancer [7]. The second screening
technique is the digital rectal examination (DRE) [8] that consists in the
insertion of one finger in the rectum to directly feel anomalies in the
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prostate. However, these exams are controversial among the scientific
community, for example, the PSA has been shown to increase the risks of
overdiagnosis that usually implies overtreatment [9] and DRE considered
to be ineffective [10, 11]. Moreover, both tests are lacking evidence of
benefits in reducing the mortality of the disease [12, 8]. Concerns related
to the overtreatment (i.e. unnecessary biopsies) are supported by several
harms that may result from the treatment (i.e. loss of sexual functions,
blood in the urine) [13, 14].
Since screening is not accurate enough to detect prostate cancer, these
methods are often used as a procedure to decide between doing biopsies
or not. High values generally require a biopsy, a process that consists of
the direct removal of prostate samples using a special needle [15]. The
process is usually performed transrectally and implies some risks to the
patient due to the invasiveness of the procedure, thus, since the mid-1980s,
ultrasound images have been used as a guide, and by 2014 it was still
the most common approach [16]. However, prostate cancer cannot be
properly detected by ultrasound images since these have poor resolution
while displaying soft tissue [17] leading to poor quality and rigour of
biopsies. More recently, studies on multi-parametric magnetic resonance
images (mp-MRI) have shown not only a better quality in identifying
prostate cancer [17] by detecting cancer that was missed by traditional
blind biopsies [18, 19, 20], but also decreasing the cases of overdiagnosis
by 89.4% [21]. Thus, for the purpose of this thesis, mp-MRI is the medical
imaging technique used and it is further detailed in Section 2.3.
Over the years, several researchers have attempted to build systems,
both hybrid and fully automatic systems, that could help humans diag-
nosing the disease. The development of these systems required different
techniques, where the most common were machine learning algorithms.
Endeavouring to diagnose the disease by detecting and grading lesions,
early research covered prostate segmentation, lesion detection, lesion clas-
sification, and lesion segmentation. Some of these tasks led to the creation
of challenges and competitions as a way to motivate the research on those
topics. ProstateX [22] for clinical significance classification of lesions and
the ProstateX2 [23] for lesion detection are some of those challenges, in
which automated methods achieved promising results. In recent years,
exponential growth in computer power, development of new machine learn-
ing algorithms and the integration of them with computer vision led to
a significant improvement of computer-aided diagnosis systems (CAD).
2
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The whole new approach, called deep learning, required no handcrafted
features and was the source of significant improvements, not only in other
fields, but also in cancer screening, with some systems able to outperform
radiologists [24]. Chapter 2 explores previous research on the topic with
Section 2.2 focusing on details regarding deep learning and Section 2.4
diving deeper into computer-aided diagnosis systems.
This thesis presents a research study on a recent dataset (IMPROD) [25]
[26] that contains samples of mp-MRI images, biomarkers, segmentation
masks and lesion scores for 157 men with prostate cancer. The dataset
is further explored in Chapter 3. The two main problems addressed in
this thesis are the classification of lesions, including PIRADS and clinical
significance, and the detection and segmentation of the prostate cancer
lesions. For these problems different experiments were performed on
the dataset, firstly using a convolutional neural network (CNN), named
XmasNet [27], to classify lesions regarding its clinical significance and a
variation of this architecture to predict the PIRADS score and and for the
other ones regarding the detection and segmentation of lesions on spatial
images using two neural network architectures called 3D UNet [28] and
a pretrained 3D ResNet-18 [29]. The latter experiments were evaluated
in two different problems in an attempt to explore their capabilities with
prostate segmentation before applying it to lesions. Moreover, the archi-
tectures have shown results in a variety of different image segmentation
problems. Experiments are respectively detailed in Section 5.2 and Section
5.3 after introduction of the methods to be used in Chapter 4. Finally in
Chapter 6 results are discussed and the thesis concluded.
3
2. Background
Ever since computational methods could learn from data, prostate cancer
has been studied, with more recent techniques being applied directly to
medical images. The interaction of these methods with humans has been
evolving, from methods that required human fine-tuning and corrections
after the prediction, to algorithms that can predict with enough quality to
be considered automatic.
In this chapter, the current clinical practice for diagnosing prostate
cancer is described. Moreover, the advantages and disadvantages of the
current methodology are explored.
Deep Learning techniques are also introduced and contextualized with
the requirements of the problem, based on previous research on similar
topics. Furthermore, it is explained how multi-parametric magnetic reso-
nance images work, and why they should be used to detect, segment and
classify prostate cancer lesions, due to the differences in the contrast of
those regarding soft-tissue appearance against common CT images.
Finally, previous research on computer-aided diagnosis systems for prostate
cancer are discussed with previous deep learning-based CADs being men-
tioned and some details explored.
2.1 Prostate cancer: current clinical practice
Manually diagnosing prostate cancer is a challenging process that requires
a considerable amount of expertise, diligence, and potentially several test
examinations. Thus, the process is rather expensive and time consuming
that has a high rate of overdiagnosis. Treatments are also frequently
associated with a myriad of secondary effects with distinct types of severity.
The process of diagnosing and treating prostate cancer is frequently
divided into four main phases. First, the screening where an expert tries
4
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to assess by direct contact or blood analysis if cancer is present. Medical
images are captured and analyzed to guide the third phase, the biopsy,
which is used to confirm the presence and severity of cancer. The latter
phase is rather invasive and may lead to potential harm. Finally, the
treatment phase, where previously captured or new medical images can be
used to guide the surgery. In the following paragraphs, these four phases
are described and explained, and the potential automatization of those will
be discussed, either to reduce the required resources, the required time, or
to decrease the overdiagnosis.
2.1.1 Prostate cancer screening
Prostate cancer screening is used to detect suspicions of prostate cancer,
however, it is also used in individuals without symptoms, but that might
have an undiagnosed tumor [8]. Screening is usually the first step in
the detection of prostate cancer, and it may improve the chances of early
detection. The screening tools used by doctors are the digital rectal ex-
amination (DRE) and the analysis of the prostate-specific antigen (PSA)
in the blood. And despite their frequent use, some experts disagree with
their value, especially when thresholded with the potential harms of the
overdiagnosis leading unnecessarily the patient to the subsequent phases
[30]. Considering the risks and the advantages of these techniques [31, 32],
patients frequently are invited to decide jointly with the responsible doctor
if they should perform the screening exams or not [33].
A DRE requires a doctor or a specialized person to introduce a gloved
finger into the rectum to feel the prostate in an attempt to detect anomalies
with its size. Its use is frequent in clinical practice as the first screening
test, however, several studies, institutions, and experts have questioned
the use of this test [11, 10], whereas others recommend this test to be used
as the second line of test, one that should be used after PSA tests [34].
Testing for the presence of the prostate-specific antigen can be useful
to detect anomalies in the prostate, therefore, it is used as a screening
method. The PSA is produced in the prostate and can be detected with a
blood test and a low quantity of this antigen in the blood indicates that the
prostate is healthy. Yet, prostate cancer is not the only potential problem
to raise the quantity of this antigen in the blood [35], because prostatitis
and benign prostatic hyperplasia can also be possible causes [36]. It is
clear that PSA is not enough to diagnose prostate cancer, and that it might
led to overdiagnose that is the cause of considerable harms due to further
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unneeded treatments. Thus, it is also recommended to not administer the
test to young men due to the fact that it would potentially diagnose cancers
that did not require immediate or future interventions [37].
2.1.2 Image-guided prostate cancer biopsy
Generally, image-guided prostate cancer biopsy is performed when there is
at least a minor suspicion that prostate cancer may be present, for instance,
high values in the prostate-specific antigen blood test, or anomalies found
in the digital rectal examination. It is an invasive procedure that consists
of the introduction of a special needle to remove samples from the patient’s
prostate for further tests and exams. It requires the introduction of the
needle either in the urethra, the perineum, or transrectally, however, the
latter is the most frequent[38].
There are two distinct types of prostate biopsies, one where ultrasound is
used to guide the intervention (TRUS), and another where MRI images are
used. Despite being widely used, and frequently mentioned as the most
common method [39, 16], TRUS biopsies have, since 2005, lost ground
to MRI-guided biopsies due to a better soft-tissue resolution, and higher
potential to characterize prostate cancer [17]. In fact, the MRI-guided
biopsies’ potential was already shown in practice, and its ability to detect
more cancers [19] is verified by studies that confirm that it improved the
detection of clinically significant prostate cancers by 17.7% [21]. Moreover,
it also reduced the overdiagnosis by 89.4% [21], and the correlation between
the biopsy and the pathology is higher when using MRI-guided biopsies
[40].
As a consequence of the invasiveness of the procedure, some harm might
be inflicted on the patient as a side effect. The most frequent side effects
include blood in the urine, in 31% of the cases, rectal pain, burning when
urinating, poor erections and urinary infection potentially requiring hos-
pitalization [41, 42]. Due to this fact, in some cases, where there were
previous negative biopsies, experts may recommend only the analysis of
an MRI image if PSA values continue increasing [43].
One of the areas that can benefit most of the automation is the analysis
of medical images of prostate cancers. Firstly, the process of having a
doctor annotate MRI images manually, either to guide a biopsy or to
analyze the cancer lesions, is expensive and time consuming. To extend
the implementation of this technique is crucial to reduce the costs, and
here automation can assist if it succeeds to annotate the images with the
6
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same precision of the expert. Furthermore, if the annotation quality is
increased by an automated tool, it might represent fewer biopsies, and
fewer treatments, by reducing overdiagnosis. The reduction of these two
interventions potentially could greatly reduce the risk of side effects and
harm to the patient.
2.1.3 Prostate cancer treatment
Treating prostate cancer is challenging and often it requires a combination
of surgical and non-surgical interventions [44]. Cancers in a more advanced
state sometimes spread to other parts of the body near the prostate, endan-
gering more organs and creating difficulties in the treatment. Therefore,
these require special treatments such as hormonal therapy and chemother-
apy, with minor exceptions, for example, when there is a limited amount
of metastasis, sometimes radiation treatment is used [45]. Other less
advanced tumors can be treated with surgery, external beam radiation
therapy or cryosurgery. However, it is not wise to combine radiotherapy
after a failed surgery since it may cause other problems (e.g. different
cancers) [46, 47]. Both these procedures have similar prospects for the side
effects after a five-year period [48].
Despite all the available treatments, radical prostatectomy is the main
treatment for prostate cancer. Its effectiveness has been growing in re-
cent years, with robotic-assisted procedures not only being available and
common [49] but also reducing the stay in the hospital [50]. Both this
procedure and radiotherapy have significant side effects that can inflict
harm, to the patient, that may considerably affect his life. Within the side
effects, we can include stress urinary incontinence and erectile dysfunction.
The latter affects nearly all the patients that undergo treatment [51].
2.2 Deep Learning
Deep learning is the usage of deep neural networks (i.e. a neural network
with several hidden layers stacked) to tackle problems ranging from natu-
ral language processing to computer vision and speech recognition [52]. It
has been growing throughout the years, since the publication of the paper
describing an architecture of a deep convolutional neural network called
AlexNet that won the ImageNet challenge in 2012 by a considerable mar-
gin against traditional methods (e.g. previous state of the art algorithms)
7
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Figure 2.1. Examples of use cases of deep learning with pose estimation, object detection
and object segmentation with the respective models KeypointRCNN, MaskR-
CNN and DeepLabV3.
Image from the following blog post - https://pytorch.org/blog/torchvision03/
[53]. The performance in the challenge of these networks is now superior
to the performance of humans [54].
Further research showed that deep learning was not only able to outper-
form previous models and techniques on classification problems, but it was
also able to become the state of the art in a myriad of other problems such
as the translation of a text to other languages, the detection [55, 56] and
the segmentation [57] of objects in images. Figure 2.1 shows examples of
some computer vision tasks and models, such as pose estimation, object
detection and segmentation. These models can be used to detect a variety
of objects from images, with slight variations, such as drawing a bound-
ing box around an object or creating a segmentation mask for the object.
There are plenty of different applications for these models, and they range
from biomedical applications [57] to autonomous vehicles [58] and video
description [59].
From these methods, the segmentation is the one with more successful
applications in biomedical domains, such as segmentation of cancer lesions
[60], which is one of the main problems, applied to prostate cancer, that
this thesis tries to solve. This section and respective subsections focus on
the necessary deep learning foundations to be able to solve the proposed
problems.
2.2.1 Artificial neural networks
Some computational algorithms were built based on and inspired by a
specific biological system. One of these algorithms, called Artificial Neural
8
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Networks, was inspired by the nature neurons present in biological systems
like the human brain.
f(x)
x1
x2
y1
Figure 2.2. An Artificial Neuron (also known as perceptron), basic unit of neural networks,
with 2 input values, and one output value subject to the function f(x).
Similarly to what it is possible to observe in nature, an artificial neural
network has a basic unit, the artificial neuron. However, for historical rea-
sons, the unit is sometimes called the perceptron and it is shown in Figure
2.2. Several of these artificial neurons can be stacked either vertically or
horizontally in order to create more complex compound units able to learn
how to approximate nonlinear functions.
To interact with the perceptron, it is necessary to feed it input values #»x to
which it is applied a function f( #»x ) that originates output values #»y . Either
#»x and #»y can be represented with one or multiple values. As mentioned
previously, these structures learn how to approximate nonlinear functions,
however, f( #»x ), the applied function, is just a representation of a linear
function f( #»x ) = wt #»x+b, where both b andw are learnt values, denominated
respectively as bias and weights. Therefore as an attempt to approximate
those nonlinear functions, researchers introduced nonlinearities after each
function, called activation functions. Some of the most popular activations
functions are the Tanh function, the Sigmoid function, Softmax function
and the rectified linear unit (ReLU) [61], and while those are broadly used
some other activations, such as Mish [62] and Leaky rectified linear unit
(Leaky ReLU) [63], have been used recently, showing promising results in
some use cases.
#»y = ϕ(f( #»x ))
= ϕ(wt #»x + b)
(2.1)
As a result of including this activation in our artificial neuron, the output
9
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is now given by the expression shown in the equation 2.1.
ReLU: ϕ(xi) =
⎧⎪⎨⎪⎩0, if xi ≤ 0xi, if xi > 0 (2.2)
Sigmoid: ϕ(xi) =
1
1 + e−xi
(2.3)
Softmax: ϕ(xi) =
xi∑
j e
x
j
(2.4)
Equations 2.2, 2.3 and 2.4 represent three of the most popular activation
nonlinearities that are useful and important to the scope of the problems
addressed in this thesis. Each one of these activations has particularities,
either in the range of the output, the computations needed to computed and
the derivative, or the circumstances where they are seen as particularly
useful. ReLU, equation 2.2, has been used frequently as the activation
that follows a convolutional layer (see subsection 2.2.3) since it has been
shown that they usually improve deep neural networks training [64]. The
computations needed to calculate this activation and its derivative are
minimal, and the output ranges from [0,∞[. While the ReLU range does not
limit a maximum value to the output, both sigmoid and softmax functions
limit the output to a value in the interval [0, 1[. The sigmoid activation,
equation 2.3, is particularly useful and popular for binary classification
problems, for instance, when classifying if an image is from a dog or not,
the output, between 0 and 1, can be interpreted as a probability of being a
dog. On the other hand, the softmax activation, equation 2.4, is widely used
on multiclass classification problems, due to two particular characteristics.
First it is its range, and secondly the fact that it is a function of all the
output values, in a way that the sum of the softmax of all the output
values must sum to 1. Thus enabling it to be interpreted as a probability
of belonging to that class, in other words it normalizes the outputs of one
node based on the value of all nodes.
In Figure 2.3 it is possible to observe the behavior of the three nonlinear-
ities and compare them with the linear function. It is also worth noting
that despite having the same scale on the x-axis in all the plots, each of
10
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Figure 2.3. Behavior of the ReLU, Sigmod and Softmax activation functions compared
with the linear function. It is worth noting the scale of the y-axis in each plot.
them has a specific scale for the y-axis. This is of particular relevance
when comparing ranges of functions, their progression and the impact that
it may have on training (e.g. what if all the values are 0 before being given
to a ReLU nonlinearity). However, despite allowing the network to learn
more complex functions, the introduction of nonlinearities transforms the
optimization problem in a non-convex optimization problem, meaning that
it is now more complicated to optimize when compared to a convex problem
[65].
An artificial neural network is not only characterized by the number of
input values, the number of hidden layers with the respective number of
nodes and the number of output values, but also by how these layers and
each node is stacked and connected to the others. One of the oldest and
more popular neural networks is the feed-forward, and it contains several
layers, the input, and output layers and also a stack of one or more hidden
layers. However, each layer has also a stack of artificial neurons (or nodes),
increasing the number of nodes increases the complexity of the learned
function but also makes the training process more difficult. The same
happens when the number of hidden layers is increased. The layers of this
network are usually denominated as fully-connected layers, as a result of
the fact that every node of the layer n feeds its output to all the nodes of
the layer n+ 1 as input. In other words, this means that a simple network
11
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Input Layer Output Layer
Hidden Layer
Figure 2.4. A simple fully connected (also known as feed forward) artificial neural network
with 4 input values, 1 hidden layer composed of 5 neurons and 3 output values.
as seen in Figure 2.4 contains, if all the bias are ignored, 35 parameters to
be learned in the optimization process.
2.2.2 Optimization of neural networks
Due to its non-convex nature, artificial neural network optimization cannot
be solved by an analytical mathematical expression. Instead, an algorithm
that is a special case of reverse accumulation, designated back-propagation,
must be used [66, p. 217-218]. This algorithm solves the values of the
parameters (weights) of a neural network in an iterative two-step process,
the forward and the backward step. Despite being independent algorithms,
back-propagation often takes advantage of the gradient descent algorithm
to update the weights and try to find a solution [66, p. 200]. Despite the
fact that configuring the hyperparameters carefully usually allows the
algorithm to get a solution that has the reqired performance in practice,
there is no guarantee about finding an optimal solution or even a solution
that is close to the optimal. Optimization of neural networks is usually
called the training of the network, and only during training, the backward
step is computed.
In order to know how to update the network, and to be able to integrate
gradient descent, it is necessary to give an objective to the optimization
process. Therefore, during training, besides the input, #»x , and the output, #»y ,
it is necessary to have a label representing the expected value for #»y [68, 69].
12
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Table 2.1. Loss functions and the type of machine learning problems where they are
frequently used.
Name Problem
Cross-Entropy loss Classification
Logistic loss Classification
Dice loss Image Segmentation
Focal Loss[67] Detection
Mean Square Error Regression
Frequently this label is mentioned as ground truth. Some optimizations
do not require labels (e.g. unsupervised learning) [70], however, for the
scope of this thesis, only supervised learning is covered. In supervised
learning problems, during training, the objective is to obtain an output
each iteration closer to the ground truth, and the closeness of both is
computed using a loss function. Loss functions generate what can be seen
as a numerical error that can be used to analyze the performance of the
model. A proper optimization algorithm can, through the minimization
of the error, update the weights of the network in a way that will better
approximate the optimal function and generate results closer to the ground
truth.
There is a myriad of different loss functions, each of them having dif-
ferent properties, advantages, and disadvantages, being arguably more
appropriate to one type of problem than to others. Some of these can be
seen in Table 2.1 with a reference to the type of machine learning problems
where they are frequently used.
The forward step was previously described, and it is the process used
to generate an output from an input. After computing an output during
training, the next step is to compare it with the ground truth through the
calculation of an error, using, as mentioned before, a loss function. The
backward step then takes advantage of a dynamic programming technique
to compute, with the chain rule, the gradients of the input with respect
to the loss function. This process goes from the last layer to the first,
computing each gradient in one whole iteration, and, for instance, does not
repeat redundant computations in order to compute the gradients of some
layer [66, p. 200-220]. The gradients are then fed to a gradient descent
algorithm that will perform a gradient step, which is used to finally update
the weights [66, p. 200]. Different variations of gradient descent can be
used, such as mini-batch gradient descent, which uses a small batch of the
training set at each gradient step, or stochastic gradient descent, which
13
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uses only one sample per gradient step [71, p. 303-307]. These variations
frequently reduce computation cost (e.g. not all the data is loaded in the
memory or in the GPU) and help to avoid local optimums, however, the
convergence rate decreases [72, p. 351-368].
In the inference phase, no gradients are computed and new samples are
given to the network. The network must be able to generalize and have
error margins in never seen data close to the ones given in the training
set, after training. When this does not happen it is said that the network
overfitted the training data and strategies to avoid this problem range
from reducing the complexity of the network to adding a regularization
term to the loss function or increasing significantly the number of training
samples [73, p. 1-12].
2.2.3 Convolutional neural networks
The application of deep learning and deep artificial neural networks to
computer vision tasks led to the detection of a problem with feed-forward
models. Even small images have a large number of pixels, for example, a
128x128x3 (height x width x color channels) image contains 128 ∗ 128 ∗ 3 =
49, 152 pixels, which represent the number of nodes in the input layer. The
effect of these pixels get worse when we consider that the next layer will
connect all the nodes to these input nodes, and that complex tasks require
more nodes. Thus, a model that receives this image has 100 nodes in the
second layer and five outputs totaling 49, 152 ∗ 250 + 250 ∗ 5 = 12, 289, 250
parameters to be optimized. Optimization of such a large number of
parameters is rather complicated, despite the fact that the network shown
is not even a deep neural network.
To construct feasible networks that work with images as input, re-
searchers started replacing most of the fully-connected layers with con-
volutional layers. Networks with these layers are called convolutional
neural networks (CNN). Inspired by biological receptive fields, the CNN
architecture mimics, to some extent, this feature of the animal visual
cortex [74, 75]. The aforementioned receptive field is used by animals as
detectors, to detect special characteristics in an image, such as edges. The
approximation can be achieved with the convolutional operator [76].
A convolutional layer, the main building block of convolutional neural
networks, is typically defined by a set of filters/kernels, which are the
representation of their weights. Despite going through all the input, these
filters are usually considerably smaller than the input size. In order
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Figure 2.5. Visual representation of a convolution happening in a 2 dimensional input of
size 6x6. This convolution has dilatation of 0, stride of 3, padding of 0 and a
kernel size of 3. The output is of size 2x2
to detect the spatial characteristics of the input, each kernel is used to
compute the dot product between the kernel and the image, throughout
the entire width and height, generating an activation matrix similar to
what can be seen visually represented in Figure 2.5. This process can also
be mentioned as a convolution operation. Furthermore, it also includes a
third dimension, the channels where the size of that dimension represents
the number of stacked filters to be used in the convolution. Using this
dimension is what allows one convolutional layer to be able to learn several
features in the spatial representation of the input in one single convolution.
These characteristics might be useful for future layers to understand and
learn more complex spatial shapes.
Besides the filters dimension and the number of channels, the output
shape of these layers is controlled by other hyperparameters that require
careful attention and tuning to approximate. The three hyperparameters
are dilation, stride, and zero-padding.
• Stride - Represents the movement of the filter along with the image
height and width, it affects the size of the output since a larger stride
will represent a smaller sized output [77]. If the filter is seen as a sliding
window that moves around the input, the stride is the step size, in terms
of pixels, that the sliding window should move. If the stride is smaller
than the size of the kernel, it means that there will be overlapping
between activations in the output, otherwise, the same input pixel will
not be in more than one activation.
• Dilation - The filter usually convolves on a specific size of consecu-
tive pixels, however, sometimes it is useful to utilize a specific type of
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convolutions, called dilated convolutions [78]. This parameter, dilation,
represented by an integer, is the spacing between each pixel to be con-
volved, i.e. a regular convolution has dilation of 0 since there are 0 pixels
of spacing between each pixel to be convolved in the input.
• Zero-padding - Some use cases require that a padding of 0’s is added
to the input, this increases the size of the input and is usually used to
control the spatial size of the output, for example, when it is required
that the output size is the same of the input size.
Dim(Y ) =
Dim(X) + 2 ∗ P −D ∗ (K − 1)− 1
S
+ 1 (2.5)
The output size Dim(Y ) can be written in function of the input size
Dim(X), the filter size K, the stride S, the dilation D and the padding P
by the expression given in the equation 2.5 [79].
In convolutional layers, the optimization process does not try to optimize
the weight of every single neuron, what it does is optimize the existent
values in the sliding window. There is an assumption that if the values of
the kernel are able to acquire information at some spatial position, they
should be able to do the same in the others. In other words, it means that
if a convolutional layer is composed of five channels, each with a filter of
size 4x4 and it gets as input a 128x128x3 image, the number of parameters
of the layer will be 5 ∗ 3 ∗ 4 ∗ 4 = 240. This characteristic, that is mentioned
as parameter sharing, contributes to two main aspects that might improve
the computational performance and the results obtained. The first one is
that it does contribute to the translation invariance characteristic that
is frequently associated with CNN. Secondly, they require considerably
fewer parameters, easing the optimization of the network, and allowing
its design to be deep (i.e. include more layers) [80]. The optimization
of convolutional neural networks can be done, similarly to feed-forward
networks, with backpropagation and gradient descent [81].
Besides convolutional layers, convolutional neural networks frequently
have max/min/average pooling layers that try to reduce the spatial repre-
sentation of the image by using a sliding window and max, min or average
operations to pick the output value. These layers are particularly useful to
reduce the size of the input, however recently researchers have discarded
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them [82] or reduced the size of their filters [83].
To finish a convolutional network architecture, usually, one or more fully
connected layers are added to do the high-level reasoning. This works
similarly to what was shown before regarding artificial neural networks,
including the activations. Including several of these layers might have a
negative impact on the computational cost, thus usually only one to three
are added after several layers of convolutions and poolings.
Figure 2.6. Visual representation of a convolution happening in a 3 dimensional input of
size 6x6x1. This visualization shows the capture of a single activation using a
kernel size of 3x3x1. The full output is not displayed.
While this subsection focused on convolutional neural networks working
in two dimensions, the architecture is not limited to it. Convolutions on
three dimensions are possible, and they work similarly, however instead
of a sliding window (2-d kernel), it is used a sliding cube (3-d kernel). In
Figure 2.6 it is possible to observe a simple case of how these convolutions
work to generate one entry of the output matrix.
2.2.4 Image segmentation
Similar to other research fields, computer vision has also benefited from
the rise of deep learning-based methods. Not only previous results were
improved in a myriad of tasks and use cases, but also the process was sim-
plified due to the fact that deep learning does not require manual feature
extraction. One of the most frequent topics to be mentioned in research
articles is image segmentation, that is other words can be described as the
process of dividing an image, given as output, into segments. Some images
can have their analysis simplified simply by changing their representation
to something with more significance to the problem [84, 85].
Segments can vary accordingly to the problem, however, frequently the
main use of image segmentation is to find segments that contain some
object, and to draw its boundaries. For instance, if a problem consists of
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Figure 2.7. Segmentation example, where the boundaries and the animal image are
segmented as separated segments. On the left it is possible to observe
the original image, on the right the 3 different segments, the back-
ground (blue), the boundaries (yellow) and the cat (purple). Image from
https://www.tensorflow.org/tutorials/images/segmentation
segmenting the ball from a football game picture, the idea is that the out-
put includes the same label in each pixel where the ball is represented and
another label (e.g. a background label) in the other ones. This representa-
tion not only gives the position of the ball, as it gives its boundaries too.
Figure 2.7 shows an example of a segmentation problem, where the goal
is not only to segment the cat, but to segment separately the boundaries
between the cat and the background.
The interception of image segmentation with other research areas also
led to significant advances and some even more promising future prospects.
One of the areas, where it has been applied to, was medical imaging
[86, 87], with several uses cases, such as detecting and segmenting tumors
[88], surgery planning and studying the anatomical structure to detect,
and diagnose problems [89].
2.2.5 Data augmentations for biomedical images
Training a regular artificial neural network takes a considerable amount
of time and data, and some specific areas, such as deep learning, where
the neural networks also extract the features from the data, it is required
even larger volumes of data. This is also true to avoid problems like
overfitting, which might hurt the performance of the network when it is
exposed to never seen samples, due to the fact that the complex model
fitted almost perfectly the testing data, decreasing the generalization
capabilities. Moreover, it is important that the data has representations of
a great part of the input data distribution, so it can properly approximate
the real distribution, in other words, when trying to segment prostate
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lesions it is important that the model trains on different tumors shapes,
sizes, and aggressiveness.
Constructing a large medical dataset is an almost impossible task due to
diverse factors. To start with the labeling of the samples must be precise,
accurate and correct, which requires expert knowledge. Nevertheless, not
only the price of these radiology experts is rather expensive, the process
of manually annotating the labels in a medical scan is time-consuming,
and a complicate process. Hence, the datasets provided by these clinical
experts are frequently small in size. Furthermore, recently the restrictions
imposed by privacy laws created extensive problems for the investigation
labs, health institutions or clinical trial lab to combine their data and joint
efforts to create a large meaningful dataset for deep learning. Comparing
to other Computer Visions datasets with millions of available samples
for training, the frequently less than one thousand samples in medical
images datasets shows the lack of proper data in these problems. Moreover,
medical images are frequently represented with one color channel, which
can be seen as one extra challenge to the learning process.
There are, however, techniques that were created as an attempt to bypass
this problematic lack of data. The technique with the most success cases is
called data augmentation, or more specifically image augmentation when
referring to image data. Since one of the advantages of having a big dataset
is to have a high variation in the data which drives the network to focus
on the important features instead of focusing on specific of each image,
these techniques apply small random transformations to the data. The
application of these augmentations can be done statically and applied to all
the dataset, however, the best results have been attained with generators,
that will apply on the fly the augmentations to an image randomly varying
the magnitude and which transformations are applied. Generators usually
help to further tackle the overfitting problem.
Several transformations that can be applied to the data, however, not
all of them are appropriate to be used in medical images. Considering
the impact that the features of medical images are important, and should
be preserved, the most frequently used augmentations include the use
of linear transformations. These can be divided into rigid and non-rigid
transformations, with the latter not keeping the image shapes unchanged.
Some of the rigid transformations are translation, rotation, flipping.
• Translation - Shifting of the image towards some direction, changing
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the absolute position of the image elements.
• Rotation - Rotating the training image by a randomized number of
degrees.
• Flipping - Due to the fact that anatomical structures are, in several
cases, symmetric, this technique mirrors the image either vertically or
horizontally. This also tackles the lack of variety of the dataset, in the
sense that images givens could, without any particular medical reason,
have the region of interest located more frequently in on side of the organ.
Examples of the non-rigid linear transformations are stretching and
shearing.
• Stretching - Zooming in and out with different ratios stretches the
image, and changes both absolute and relative features of the image.
However, this transformation must be used carefully since if its magni-
tude is too high it can hurt the model performance instead of improving
it.
• Shearing - While stretching works in one direction, shearing is a similar
transformation that consists of moving the top and the bottom, or the
left and the right side of the image in different directions. It can be seen
as stretching in two directions.
Finally, in an attempt to improve the generalization of the model across
different medical imaging capture machines, it might be useful to apply a
transformation that will vary the intensity of the gray-scale pixels in the
image. This also helps to optimize the model in a more robust way when
the limited dataset had all the samples captured by the same machine.
2.3 Multi-parametric MRI
The complexity of the task of detecting, segmenting, or diagnosing disease
from medical images is due to several factors. First of all, not only it
requires appropriate expert knowledge so the image is properly analyzed,
but the results are affected by the type and quality of the image being
visualized. In other words, not all techniques to capture an image are
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adequate for the visualization and accurate diagnosis of either prostate
cancer lesions or the classification of the aggressiveness of those lesions.
For prostate cancer, two main imaging techniques have been used over
the years. Ultrasound (US) scan was the main technique to diagnose
prostate cancer, however, in recent years, Magnetic Resonance Imaging
(MRI) started to have its use increased in several countries. One of the
reasons for this increase is that ultrasound images have poor soft tissue
resolution whereas magnetic resonance images show better resolutions
[17]. Moreover, MRI has been used to help doctors assessing other details,
such as the difficulty of the surgical procedure, and which direction should
they follow when planning the surgery [90].
To capture an image of the organs of the body, magnetic resonance images
rely on radio waves and in strong magnetic fields. Since it does not use
radiation or ionization it can be seen as a better solution when compared
to alternatives like Computed Tomography and X-Rays. However, MRI
requires longer capture times, which can become an obstacle when this
technique becomes widely used on a higher number of patients. The
mapping of the organs is based on the detection of water and fat in the
body through the interaction and excitation of hydrogen atoms present in
those biological tissues. Small changes to the configuration can generate
different types of images with a huge variety of contrasts and use cases
applied to different diagnoses, these different types are frequently called
sequences. When a magnetic resonance image is composed of two or more
sequences, it usually is called multi-parametric magnetic resonance image
(mpMRI) [91] [92]. Some of the most common sequences are T1 weighted
(T1W), T2 weighted (T2W), diffusion-weighted image (DWI) and apparent
diffusion coefficient (ADC). Each of these sequences captures different
details, therefore they have different uses based on the problem to analyze
and diagnose (e.g. DWI and T2W are frequently seen in prostate cancer
studies).
2.3.1 PI-RADS
Prostate Imaging Reporting and Data System, also known as PI-RADS
is a set of standards to capture and report prostate cancer images with
mpMRI and assess from them the risk of clinically significant cancer being
present. The first version of these standards was especially focused on
the clinical significance classification [93], whereas the second version, PI-
RADSv2, focused also in creating global standards for MRI [94]. Overall,
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both versions aimed to improve the quality of image capture and reporting.
A plethora of studies have tried to assess the impact of these standards
across the entire workflow of a prostate cancer diagnosis. Both versions
have shown positive results in classifying clinically significant prostate
cancer lesions [95, 96], however, some limitations regarding the classifica-
tion of small (≤0.5mL) significant lesions (GS≥4+3) have been noticed [96].
Furthermore, PI-RADS has proved to be useful in other applications as
the detection of the extension of cancer outside of the prostate [97] which
is an important step in the staging of the cancer. Predicting when the
active surveillance termination period should be defined, based on the
aggressiveness of lesions, is another of the uses of this set of standards
and evaluation criteria [98].
Table 2.2. PI-RADS scores [99]
PI-RADS Probability of clinical significance
1 Very low
2 Low
3 Intermediate
4 High
5 Very High
Table 2.2 shows the scores that compose the PI-RADS score system and
their meaning in terms of risk of the cancer being clinically significant.
2.3.2 T2W
After excitation, tissues affected follow a relaxation process, on T2 weighted
a specific relaxation process, by the name Spin-Spin relaxation, is used in
order to generate the image. This process of capturing the images is based
on the decay of the transverse component of the magnetization vector to
an equilibrium state. The decay is exponential and the time necessary to
reach the equilibrium given in function of a constant known as spin-spin
relaxation time, or T2 [100, 101]. The constant T2 (given in the order
of seconds for protons) varies, and each biological tissue has its own, for
example, water-based tissues range from 40 to 200 ms whereas fat-based
tissues range from 10 to 100 ms.
Variation in the capture time of different tissues generates different
signal intensities, therefore it is possible to observe a contrast between
some tissues and body organs based on what is in their composition. Some
of the high signals in T2W images are given by water tissues [102], such as
22
Background
(a) T2W sequence. ProstateX dataset
[22].
(b) ADC sequence. IMPROD dataset [25,
26]
Figure 2.8. Visualization of T2W and ADC slices, from a mp-MRI of the prostate, side by
side.
inflammation, edema, tumors or infections [103] whereas bone, air, protein-
rich fluids, and fibrosis originate low signals [102, 103]. The representation
of a high signal is a white, brighter pixel while a low signal is represented
by a darker pixel. In Figure 2.8a it is shown an example of a T2W image of
a prostate MRI.
2.3.3 DWI-ADC
The diffusion of water molecules in tissue is constrained and affected by
the interaction of water molecules with different components of that tissue,
such as fiber and proteins. Images are generated through the analysis
of water diffusion patterns that are used to map the microarchitecture of
biological tissues into an image with the appropriate contrast to detect and
diagnose diseases and anomalies [104, 105]. Images generated with this
technique are called diffusion-weighted magnetic resonance images (DWI).
The composition of a tumor, frequently highly cellular, which originates
more constraints to water diffusion allows this type of pathology to orig-
inate a high signal in DWI images [106]. Hence, this sequence type is
frequently used to detect, stage and monitor cancer tumors.
Standard diffusion-weighted images have an inherent relation with T2
weighted images, which in some cases has a possible negative impact on
the image capture. For instance, lesions that do not restrict water diffusion
are not supposed to have a high signal, however, if their T2 relaxation time
is long then the pixels will be bright [107]. To reduce this effect, a special
type of DWI, called apparent diffusion-coefficient (ADC), is used. The
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capture of an ADC image requires several diffusion-weighted images to
be captured with different weights, the rate of diffusion is then calculated
from the change in the signal between weights. Despite the similarities
and the relation between ADC and DWI, the second uses bright pixels to
represent constraint movement, whereas ADC uses dark pixels for that
representation [108]. In Figure 2.8b it is possible to observe an example of
a ADC image of a prostate MRI, and it is also possible to observe that this
image has frequently lower resolution when compared to T2W images, as
can be seen by comparing with Figure 2.8a.
2.4 CAD to prostate cancer
Several researchers have attempted to develop solutions that would help
to diagnose prostate cancer. These solutions varied greatly in their method-
ology, not only in terms of deep learning models, but in the way that they
saw the problem. For instance, some solutions tried to classify the clinical
significance of lesions from diffusion-weighted images using a dataset with
427 patients [109]. Others directed their efforts to segmentation problems
from these magnetic resonance images.
Since it is an easier problem, considerable research was conducted for the
prostate segmentation with varying results regarding different datasets
and methodologies. For this problem, some researchers used only T2W
sequences, either from public datasets such as PROMISE12 [110] or private
[111]. In an effort to further increase the performance of single sequence
segmentation, some other researchers co-registered both DWI/ADC images
with T2W images. While in some cases this was the only approach [112], it
is possible to see in others that the co-registration, in fact, increases the
performance when compared to single sequence inputs [113].
Some authors decided to conduct more extensive experiments and efforts,
endeavoring to detect and segment prostate cancer lesions from these
images. The results reflected the hardness of the task at hand, and in
some cases, neither of the independent sequences or a combination of both
was enough to surpass a dice score of 0.60 [113]. However, there has been
some progress with some solutions obtaining a dice score of 0.64 which is
considerably closer to the reported dice score for two expert clinicians of
0.67 [112].
A myriad of other techniques was attempted ranging from traditional
machine learning with features extracted and treated manually by re-
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searchers, probabilistic methods, and others that required post-processing
of the output by experts. Since the main focus of this thesis is the use
of deep learning based methods, the focus of this section was in those
methods previously developed by other researchers.
25
3. Improd Dataset
Recent progress in machine learning and deep learning research has been
backed up by the improvement of public datasets for a myriad of domains.
These datasets allow a more objective evaluation of the methods since
they are all tested on the same data. However, that is not the case with
datasets containing prostate magnetic resonance images, since those do
not combine high image and annotations quality and different types of
annotations. Therefore, for this project, the existence of a private dataset,
IMPROD, reuniting all this characteristic is of greater importance, even
if the objective comparison with other work might be slightly affected.
Moreover, not only the quality is important, but the size and some other
statistical details of the dataset are important.
The analysis of a dataset includes several questions to be answered such
as "What is the source of the dataset?", "How was the dataset annotated?",
"Why is this dataset valuable for the problem that is being solved?" and
"How do those annotations align with the experiments necessary to solve
the problem?". Furthermore, since this dataset contains medical images it
is also important to discuss the expertise of the annotator and the quality
of the dataset. Moreover, studying if the data available is representative of
its real-world distribution that would allow generalizing to the deployment
of the model.
This chapter discusses all the previously mentioned questions address-
ing, in particular, the IMPROD dataset and its characteristics. Further
important statistics to set up, interpret and evaluate experiments using
the methods detailed in the previous chapter are analyzed thoughtfully to
understand the weaknesses and strengths of this particular dataset in the
context of this thesis.
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3.1 Source of images and annotations
The IMPROD (Improved Prostate Cancer Diagnosis - Combination of
Magnetic Resonance Imaging and Biomarkers) dataset originated from a
clinical trial conducted in a joint effort by the Turku University Hospital
and the University of Turku. The trial included 175 patients between 40 to
85 years with suspicions of prostate cancer supported by screening results
(i.e. abnormal DRE or 2,5-25ng/ml PSA in two measurements).
In order to maximize the quality, the dataset was, not only gathered using
images captured with recent and high-quality magnetic resonance scan-
ners (Magnetom Verio 3T, Erlangen, Germany), but it was also carefully
annotated by experts in the field that belong to the institutions conduct-
ing the clinical trial. This maximization of the data quality due to the
techniques used denotes an attempt to improve the outcome of machine
learning and deep learning solutions in a myriad of prostate cancer-related
problems.
From the possible image sequences captured by a magnetic resonance
machine, the selected to compose the dataset are T2W and ADC sequences
captured from five diffusion-weighted images with a b value varying be-
tween 0 and 500. Both of them are accompanied by the respective prostate
mask, and if there are one or more lesions, by the lesion masks. Distinct
lesions have different independent masks, even if the patient and the
magnetic resonance image are the same. Each sequence was manually
segmented to construct the mask of the lesions and the prostate under
the premise that despite requiring twice the necessary work, it generates
better quality annotations. Concerning the dimensions of each sequence,
T2W is the largest of them with 360x360 with a varying number of slices.
ADC, on the other hand, is considerably smaller with only 128x128, also
with a varying number of slices.
Besides images and corresponding masks, metadata of all lesions of every
patient is also gathered to facilitate development of automated methods. It
includes scores interpreted from magnetic resonance images, such as the
Gleason Grade Group and both the PIRADS and Likert scores. Moreover,
a Gleason score given is also provided allowing for potential studies on the
overdiagnosis problem too. The analysis and the classification of lesions
can be done using several approaches and interpretations of this data. In
this project, since, lesions labels indicating clinical significance are not
given directly in the dataset, they are inferred based on the provided details
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Figure 3.1. Example extracted from the IMPROD dataset of lesions masks over a T2W
multi-parametric magnetic resonance image. The figure on the left is the
second lesion of the patient identified as 28, with upper and lower images
representing respectively the consecutive slices 6 and 7. The figure on the
right is the lesion number one of the patient identified as 5, with upper and
lower images representing respectively the consecutive slices 12 and 13. Note
the lesion size difference between patients and between slices of the same
patient.
concerning each lesion. Similar to the aforementioned mask annotations,
experts from the institutions involved in the clinical trial were responsible
for given the scores of each lesion.
3.2 Clinical Interpretation of the data
Interpreting the data from a clinical perspective is crucial to understand
and solve the problem. Notwithstanding the fact that deep learning ar-
chitectures implicitly learn feature extraction, other details must be con-
sidered in order to properly set up the experiments. For instance, what
the meaning and the reason behind the distinction of a lesion as clinically
significant, or the three-dimensional representation of the data, and how
masks are visualized.
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Figure 3.2. Example extracted from the IMPROD dataset of lesions masks over a ADC
multi-parametric magnetic resonance image. The figure on the left is the
second lesion of the patient identified as 28, with upper and lower images
representing respectively the consecutive slices 3 and 4. The figure on the
right is the lesion number one of the patient identified as 5, with upper and
lower images representing respectively the consecutive slices 8 and 9. Note
the lesion size difference between patients and between slices of the same
patient.
The images are divided into three dimensions, the first two, height
and width, are common to regular two-dimensional images. The third
dimension that gives extra spatial information is in this case the slices.
This is captured by collecting prostate images in a different position with
a given spacing between them, which is relevant to the way the images
are processed. Thus, even though the same institution usually captures
the images with the same technique, there has been an attempt to create a
standard technique to collect these images, allowing them to combine in
the future several datasets.
A clinically significant lesion can be defined through several scoring
systems such as the Gleason grade groups (GGG), the PIRADS and Likert
scores given from analysis of multi-parametric magnetic resonance images.
Some datasets use the real Gleason score verified after the surgery. For this
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project, the Gleason grade group from the MRI (GS_MRI) is used. Positive
labels are given to lesions that belong to group two, whereas lesions from
groups one and zero are classified with a negative label of zero.
Figure 3.3. Example of a lesion contour in a T2W sequence. This contour is drawn from
the segmentation mask and it is only used from visualization purposes. Slice
13 from the patient with id 10.
Lesions are much less represented in the dataset than the prostate, thus
generating less positive labels and an increasingly difficult task due to a
more skewed dataset. Figure 3.1 shows the visualization of lesions masks
in T2W sequences. In the first analyzes of the image, it is perceptible
that lesions do not have the same size. Comparing this image to the one
in Figure 3.2 denotes two key details, firstly the resolution of the latter,
representing ADC sequences, is inferior. Secondly, both figures include the
same lesions, however, they are visible in different slices of each sequence,
in other words, these sequences are not registred. Moreover, in Figure 3.3
it is possible to see the contour of the lesion drawn from the segmentation
mask.
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3.3 Dataset statistics
The size and the quality of the annotations are undoubtedly important
to the quality of the learning. However, some other key factors might
influence the ability of the model to generalize to or work properly with
all the classes and potential requirements of the problem. For instance,
as previously mentioned, the classification of both clinically significant
lesions or the PIRADS score is one of the problems that this thesis is trying
to solve, and they can be affected by skewed datasets. In other words, a
dataset where one label has a much significant representation than the
others, or when one label does not have proper representation (e.g. 95% of
the dataset from the same class).
Figure 3.4. Distribution of the PIRADS score across lesions. This histogram includes all
the images and lesions in the dataset, even those that do not have individual
lesion masks, such as most of the lesions with a PIRADS score of 1.
All the lesions in the dataset are classified by experts according to the
PIRADS system, and one of the important points to the prediction of this
score is to see if the dataset has a proper representation of all classes.
Thus, in Figure 3.4 a histogram with the distribution of the scores is
shown. The most represented labels are those of the scores four and five,
accounting for more than 60% of the labels. On the other hand, label two
has a poor representation of less than 10% of the data. Despite being
present in this histogram, not all the lesions that have a PIRADS score
have an independent mask, so it is impossible to locate them in the mag-
netic resonance image. Thus, since the lesion cannot be located through
the mask coordinates they are excluded from all the final classification
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Figure 3.5. Distribution of the PIRADS score across lesions. This histogram includes all
the images and lesions in the dataset, even those that do not have individual
lesion masks, such as most of the lesions with a PIRADS score of 1.
problems. Furthermore, these lesions are lower grade lesions of labels one
and two, which might become considerably problematic due to the lack of
representation of these. The distribution of the PIRADS scores after the
exclusion of lesions without mask can be seen in Figure 3.5. It is relevant
to note that there is no lesion with a score two and only one with score one.
Figure 3.6. Distribution of the Clinically Significant (positive label) and No Clinically
Significant Lesions (negative label). The former is represented by the or-
ange slice, while the latter is represented by the blue slice and represents
most of the lesions. This pie plot only includes the lesions which have mask
representations of it and can be used in classification problems.
After removing the lesions that do not have masks and cannot be located,
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it is possible to start studying the distribution of clinically significant
lesions. The exclusion of the lesion leads to a considerable reduction in
the number of available samples for classification problems with only 149
lesions to be used. In figure 3.6 a pie chart shows the representation
of the positive and negative labels in the dataset of lesions that can be
cropped and classified by a machine learning model. In contrast to what is
seen in Figure 3.4, since clinical significance is not, in the context of this
thesis, related to the PIRADS score, the presence of no clinically significant
lesions is much higher. The majority of the dataset, 65.8%, has a negative
label, where the remaining samples 34.2% are clinically significant, thus,
associated with a positive label.
Lesion characteristics have an impact on how they are classified, and
some of those can be studied in order to optimize the solution search space
or understand the problems related to one unfitting approach. The size
of the lesion is one of those elements that are relevant to decide how to
approach the problem. Through this several analyses can be done, such
as the height-width relationship, the area of lesions and the direct impact
of those in the clinical significance of the lesions. All the images were
resampled to a 224x224 height and width while keeping intact the number
of slices.
Figure 3.7. Scatter plot displaying the relationship between the weight and the height
of lesions in T2W sequences in the slice that maximizes the area of the
lesion. Only lesions with masks are used to generate this plot that also
indicates with blue if the lesion is clinically significant or with red if it is not
clinically significant. This allows to understand the influence of the size in
the significance. Lesions are measured after a resampling of the images from
360x360 to 224x224 keeping the same number of slices.
A potential relationship between the height and the size of the lesions
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is explored in T2-weighted, in Figure 3.7 and in apparent diffusion coef-
ficient images, in Figure 3.8. Despite the original size difference, with
the resampling both of the scatter plots show provide information to ac-
quire similar knowledge and draw identical conclusions from them. T2W
lesions width values are between 2< WT2W <35 while for ADC the val-
ues are 2< WADC <25. The value fore the height, are 2< HT2W <50
and 2< HADC <40 respectively. It is also worth noting, that the abso-
lute difference between the height and the width is in the majority of the
cases limited to ten, indicating that both dimensions have similar values.
Moreover, a more careful analysis denotes that the size seems to have an
influence on the classification of the lesions as clinically significant. It is
shown that lesions with both dimensions with values below ten do not have,
with a high degree of certainty, clinical significance. However, as the size
increase, the impact in the classification seems to be blander, and although
having a larger size denotes more likelihood of being clinically significant,
it is not a sufficiently accurate indicator to draw any conclusion related to
the significance. Both images show several lesions with high dimensions
and negative labels. In 3.7 the resampling has an unnoticeable effect on
the distribution of the sizes, but since ADC sequences were resampled to
a higher resolution it is possible to notice in Figure 3.8 small consistent
gaps between the sizes.
Figure 3.8. Scatter plot displaying the relationship between the weight and the height
of lesions in ADC sequences in the slice that maximizes the area of the
lesion. Only lesions with masks are used to generate this plot that also
indicates with blue if the lesion is clinically significant or with red if it is not
clinically significant. This allows to understand the influence of the size in
the significance. Lesions are measured after a resampling of the images from
128x128 to 224x224 keeping the same number of slices.
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Several strategies can be used in order to locate, crop and prepare a
lesion to be classified. Yet, not all the strategies are adequate for this
problem, and the selection of the strategy to be used is highly dependent
on the range of sizes of lesions. For instance, if there is a broad range
of sizes, a technique that just does a crop of a fixed size centered in the
center of the lesion might be problematic. Smaller lesions crops will
include an excessive amount of background, which might interfere with
the learning since the region of interest is insignificant when compared
with the surrounding. On the other hand, if a lesion is larger than the
predefined crop size important parts for the classification might be cropped
out, also hurting the performance of the model. Therefore, knowing the size
of the lesions and how the cropping technique might affect the performance
is valuable to understand the reasons behind the success or lack of it in
further experiments.
Implications of the size of lesions are broad and affect other tasks such
as the segmentation of those lesions. To start with, a larger lesion area
impacts directly the number of positive labels in each mask, for example,
smaller lesions have fewer pixels thus fewer labels, and this interferes
with how skewed the dataset is. Secondly, a considerable variation in the
area occupied by lesions might affect negatively the performance, since
models sometimes deduct correlations that might make the predictions
more prone to a specific size. To analyze the occupied area of lesions, the
area of one lesion was considered to be approximated by the multiplication
of its width and height dimensions. However, it was only considered the
slice where each lesion had the biggest approximated area since it is the
same slice to be used in classification problems. In Figure 3.9 and 3.10,
a box plot of this area in ADC and T2W sequences is shown respectively.
And even though both show similar means, and as a consequence of higher
width and height maximum values, T2W sequences are more prone to
outliers with larger areas. This might imply problems when cropping the
lesions.
35
Improd Dataset
Figure 3.9. Box plot of the area occupied by ADC lesions. This takes into account only
the size of the lesion in the slice that maximizes its size, and only lesions
with masks are used to generate this data. Lesions are measured after a
resampling of the images from 128x128 to 224x224 keeping the same number
of slices.
Figure 3.10. Box plot of the area occupied by T2W lesions. This takes into account only
the size of the lesion in the slice that maximizes its size, and only lesions
with masks are used to generate this data. Lesions are measured after a
resampling of the images from 360x360 to 224x224 keeping the same number
of slices.
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4. Methods
In the context of this thesis, there are two central research directions. The
first of them is to approach the data to work in a classification problem,
more specifically, the classification of lesions. Whereas the other focuses on
detection and segmentation from the multi-parametric magnetic resonance
images. These problems require distinct approaches and methodologies,
as well as computing power, which shall be taken into consideration while
designing the model.
The classification of lesions is a broad domain due to the most variate
scores scales given to the lesions, hence this problem can be divided into
two smaller problems that follow more narrow guidelines. To start with,
a binary classification problem based on the prediction of the clinical
significance of the lesions. And, another more complex problem aiming
to predict the PIRADS score, thus a multi-class classification problem.
Both of these problems share common characteristics, however, dataset
differences and other smaller details entitle each of them to be individually
researched and explored.
Despite employing similar methods, detecting and segmenting lesions
or the prostate are two distinct problems. On one hand, the same loss
functions, models or data processing techniques can be used. On the other
hand, the methods working in one task might perform poorly on the other
one or even show strange behavior.
This Chapter’s focus is to establish the research grounds used in the
context of this thesis, as well as discuss other factors such as research
questions, problems to be solved and implications of the chosen methods.
Furthermore, it will be explained how the conducted research will proceed
for the experiments and study alternative solutions and techniques.
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4.1 Lesion classification
Prostate cancer lesions vary in shape, size, and intensity, even their ag-
gressiveness changes accordingly. Being able to define and categorize the
aggressiveness of a lesion is one of the roles of experts when dealing with
multi-parametric magnetic resonance images of the prostate. Moreover,
the classification can be performed according to the guidelines of several
score metrics and scales, requiring a deep knowledge of the problem and
years of study in order to classify them correctly. Yet, it is a tedious, expen-
sive and prone to errors task, since there is a considerable quantity of bad
diagnosis, especially overdiagnosis with some lesions being classified as
more aggressive than what they actually are.
In an attempt to solve the classification problem, two smaller tasks were
undertaken and similar methods were employed. For both problems the
input is the same, so the base model to tackle them was the same, with
some minor differences and some other distinctions in the optimization
and evaluation process.
4.1.1 Data
The original format of the data was not appropriate for the problems
at hand. Therefore, some previous processing was required to generate
appropriate input and labels that could be used in these tasks. Originally
the data was available as the 3D representations of magnetic resonance
images of the prostate and surrounding organs. However, the expected
format to solve these problems was a 2D representation of the lesions,
avoiding as much as possible unnecessary body elements.
The first step to attain the desired data format was to spatially locate
the lesions in the 3D space. Lesions were previously detected and marked
by experts, therefore the use of the masks to locate them is possible. This
also means that lesions that appear in the data but do not contain an
individual mask cannot be part of it and need to be excluded. To efficiently
locate the lesions, their domain area was approximated, and the initial
and final points were marked independently in every slice as shown in
Figure 4.1. In the figure, it is possible to see at the green starting points
and the red ending points if the lesion is interpreted from top left to bottom
right. These points can be used to draw a bounding box without predefined
size that contains the entire lesion and potentially some background too.
Alternatively, they can be used to approximate center and draw a fixed
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Figure 4.1. Example of how the lesions are located and their area approximated. The
lesion is represented by the black area. In the image in the left, the green line
represents the left most point of the lesions while the red represents the point
that is more to the right. In the image in the write the green represent the
point that has the biggest height and the red line represents the point with
lowest height. This points can be used to approximate the lesion area to a
square, or to point the center of the lesion.
size bounding box that might crop the lesion, or capture almost exclusively
background.
Following the location of the lesion at each slice, the approximated area
of these lesions was calculated on a slice basis. The slices were then
ordered based on the largest lesions size, and the one that maximized the
size was chosen. A crop to the lesion was performed in that slice and the
output of the cropping was saved as an image to input to the classification
model. The label of the lesion was respectively associated with the new
two-dimensional image.
4.1.2 XmasNet
In all the machine learning tasks the model is as important as the data,
and in this case, the same happens. Previous challenges such as ProstateX
already tried to address the clinical significance classification problem. As a
result, many submissions attained reasonable values at this task, therefore,
one of the submissions was selected to be the base of the classification
system developed in this thesis.
MPCONV + BN CONV + BN CONV + BN CONV + BN MP
Figure 4.2. XmasNet [27] based network architecture with 2 input channels, and without
fully-connected layers. Red squares represent each one channel of the input
layer. Blue squares represent each 8 channels of a convolutional layer with a
kernel size of 3, padding of 1 and stride of 1 plus a batch normalization layer
right after. Green layers represent each max pooling layers with kernel size of
2 and stride of 2.
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The selected architecture, named XmasNet achieved the second place
with an AUC of 0.84 in the ProstateX challenge surpassing traditional
machine learning techniques [27]. Additionally to the model architecture,
the submission presented also a technique to preprocess the data and feed
it to the neural network. This preprocessing is considerably different from
that was used in this project, therefore the only inspiration is the model
[27].
Figure 4.2 partially shows the model, more specifically, it shows the
common layers to both classification problems. This part is responsible
for extracting useful information from the lesions, in other words, the
features of the lesions, regarding for instance, shape, size or intensity. The
architecture despite being shown to have two input channels works also
with one input channel, depending on how many sequences are used. The
input is followed by a convolution that increases the number of channels to
32 and another convolution that keeps the number of channels. To these,
a max-pooling layer follows, down-scaling the size by half, and feeding it
to a convolutional layer that will double the number of channels. Another
convolution and max-pooling layer follow, keeping the number of channels
and halving the size again. It is also worth noting that every convolution
has a kernel size of three and padding of one and they are followed by a
batch-normalization layer and ReLU non-linearity. Max-pooling layers
have both kernel and stride set to two.
4.1.3 Clinical significance classification
Predicting if a lesion has clinical significance or not is a typical machine
learning binary classification problem. In this sort of problem, the model
predicts if an input belongs to the positive or negative classes which in
this case are being clinically significant or not respectively. The output of
the network is one single value, between zero and one, the probability of
belonging to the positive class.
In order to tackle this task, to the partial convolutional model shown
in Figure 4.2, some extra layers, as seen in Figure 4.3, were appended.
These layers are responsible for using the extracted features from the
convolutional part and compute from them the prediction, and are specific
for the binary classification problem. The output of the last max-pooling
layer is flattened to one single dimension, besides the batch dimension, and
is then fed as input to three fully-connected layers. The first layer receives
the flat vector that has a length dependent on the size of the lesion image
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Flatten
Fully-Connected
Figure 4.3. Additional layers to be added to the network for a binary classification of the
clinical significance of lesions. Green square represents the last max pooling
layer. Arrow to the write represents the flatten of the square data to a vector
that can be fed to fully convolutional layers. Yellow circle represents the
output followed by a sigmoid activation.
given to the network accordingly to the formula height∗width4 ∗ 64 = length,
for example, a 32x32 lesion image will originate a vector of length of
82 ∗ 64 = 4096. This first layer connects this input vector to 1024 nodes,
while the second layer connects the 1024 node to the 256 following nodes.
Finally, the third and last layer generates one output from all of the 256
nodes and applies a Sigmoid function in order to convert it to a probability.
The first two layers are followed by ReLU non-linearity.
BCE(y, t) = −t ∗ log(y)− (1− t) ∗ log(1− y))
=
⎧⎨⎩ −log(y) if t = 1−log(1− y) if t = 0
(4.1)
To optimize the network and to approximate the output the binary cross-
entropy loss was minimized. The expression for this loss function can be
seen in the Equation 4.1 where t stands for the expected class (one or zero),
and y is the output given by the network that ranges between zero and
one. This loss function is a special case of the general cross-entropy loss
function and is frequently used in binary classification problems. Moreover,
the stochastic optimization was performed by the Adam optimizer with a
learning rate of 7 ∗ 10−4 and a weight decay of 10−4. Each step computed
the results and afterward the gradients of a mini-batch of size 8.
4.1.4 PI-RADS classification
Classifying a lesion as clinically significant or not is a useful task, however,
it can frequently be seen as rather limiting and lacking detail. Therefore, in
a clinical environment, the PIRADS score is a better classification system
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for the lesions, since it does try to measure the likelihood of a lesion to be
from a clinical significance cancer or not. In practical terms, it means that
the network had to be changed in order to produce five different outputs.
Moreover, not only the outputs were required to be between zero and one,
but their sum had to result in the value one.
Flatten
Fully-Connected
Figure 4.4. Additional layers to be added to the network for a multi-class classification
of the PIRADS score of lesions with five possible outputs. Green square
represents the last max pooling layer. Arrow to the write represents the
flatten of the square data to a vector that can be fed to fully convolutional
layers. Yellow circles represents the outputs followed by a softmax activation.
The model used in this task was a variation from the partial convolutional
model displayed in Figure 4.2. To the last max-pooling layers, some other
layers were added, such layers are seen in Figure 4.4. For the most part,
these layers work similarly to the ones approached in the previous problem,
with the flattening of the matrix, the input dependent number of nodes
and the node count of posterior layers. Nevertheless, the output was in this
problem represented by five different nodes, where each node represents a
class or a score from the PIRADS scale. Moreover, to the output a Softmax
function is applied, so that they can be used to minimize the cross-entropy
loss.
CE(y, t) = −log
(
eyt∑C
j e
yj
)
= −yt + log
⎛⎝ C∑
j
eyj
⎞⎠ (4.2)
The optimization of the network was similar to the one described in the
previous problem, although there were small differences. To start with,
the learning size was decreased to a value of 5 ∗ 10−5 to ensure smoother
convergence, while the optimizer and the weight decay were kept the same.
The loss function was also slightly different since it had to handle all
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the five inputs and the five classes. Cross-entropy loss was used and its
equation is represented in Equation 4.2, where y represents the predictions
vector and t the ground truth class. Moreover, as seen in the equation t
can also be used as an index of the vector y.
4.2 Detection and segmentation
Analyzing a medical image is not an effortless simple task, not only it
requires a considerable amount of training and expertise, but due to low
resolution or the format of the images, some elements such as organs and
their boundaries are difficult to locate. A machine learning segmentation
model tries not only to detect these elements but to segment them and
delineate their boundaries. In the multi-parametric magnetic resonance
images, two segmentation tasks can be defined and tackled, the segmen-
tation of the prostate and the segmentation of prostate cancer lesions.
Methods for both these tasks are discussed in this section, and how the
solution for each one was approached.
For the most part, the tasks are similar with the main goal being to
predict a mask close to the ground truth mask. Therefore, similar methods
were used in both cases, similar architectures trained and tested for both
problems, and the same loss functions were also used. However, this
section focus on similarities further details on how the problems differ are
discussed in the following sections.
4.2.1 Loss function
There are several loss functions that could have been applied to the problem
at hand, however, only dice loss was picked. This loss function comes
from the similarity measure Sørensen–Dice coefficient applied to a three-
dimensional space.
DICE =
2 ∗ TP
2 ∗ TP + FN + FP (4.3)
The formula to calculate the Dice coefficient or score is in Equation 4.3 in
terms of binary data that composes the masks. The intuition behind this
score is to measure the correctly predicted values divided by the sum of
those values and all the values predicted wrongly. A perfect value of one in
this function would require that no label of one is incorrectly predicted as
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zero (a false negative) and that no label of zero is wrongly predicted as one
(a false positive). Although the binary formulation works perfectly in an
evaluation setup, it is not appropriate for training.
DICE(Y,M) =
2 ∗ Y ∗M
Y ∗ Y +M ∗M (4.4)
During the training of the model, the mask predictions are supposed to be
given in probabilities, in other words, each pixel in the three-dimensional
space is supposed to have a probability of being classified with a positive
label. While in the final output to test a prediction a threshold can be
established to attribute a label of one after that specific value, during
training the loss function must be able to work with the probabilities.
Therefore, in order to use the Dice coefficient effectively in these problems,
and to approximate the value of the real mask, the formulation to be
used is shown in the Equation 4.4. For that formulation Y represents the
predicted mask while M represents the target mask.
DICE_L(Y,M) = 1−DICE(Y,M) (4.5)
Moreover, a loss function usually measures the distance between predic-
tion and target and not the similarity, hence, the Dice Score in Equation
4.4 can be further adapted to represent a function to be minimized. The
adaptation is rather simple, and it does only require that to a value of
one, the Dice Score is subtracted. The formulation for the loss is given in
Equation 4.5. Despite not being used directly as loss, the Dice Score is also
a great tool to measure the similarity and evaluate the performance of the
model further on.
Comb(Y,M, n) =
1.5 ∗∑ni BCE(Yi,Mi)
n
+DICE_L(Y,M) (4.6)
Despite the wide use of Dice loss to optimize models in image segmenta-
tion tasks, there are other losses that can be explored and combinations
of losses. For this thesis, a weighted combination of the dice loss with the
binary cross-entropy loss was used. The formulation of this loss can be
seen in Equation 4.6 and the weights of both are respectively 1 and 1.5.
Uniting losses requires some thought and attention, for this particular
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task, the combination of these was conceived in order to try and improve
the overlapping of the predicted and ground truth mask.
4.2.2 Models
In terms of the architectures to tackle these problems, the first model to be
used was a 3D U-Net, that was specifically designed for segmentation in
medical imaging problems [28].
Figure 4.5. 3D U-Net [28] architecture. Blue arrows represent a concatenation operation
(blue cubes in the tail of the arrow are seen as red cubes in the head of the ar-
row). Red arrows represent a 3D convolution followed by batch normalization
and ReLU. Yellow arrows are max pooling operations while green arrows are
up-convolutions. The final orange arrow represents simply a convolution to
generate the output.
The 3D U-Net model architecture can be seen in Figure 4.5. It is char-
acterized by two main features in its design. To start with the model
has "deep levels" where after two convolutions operations across three
dimensions, the input is downscaled to half of the size and the number
of channels doubled. After reaching the desired depth, in this case after
three downscaling operations, the input is upscaled until it returns to the
original dimension. In spite of having, between upscaling operations, 3D
convolutions that do not change the size, the first convolution is responsible
for reducing the number of channels. Another particularity of this model
is the shortcut connections between levels, where the output of one level
in the downscaling side is concatenated to the input of the same level in
the upsample side. These shortcut connections are especially important
to ensure that no information is lost between all the convolutions, and to
ensure that spatial information is preserved from the original image and
through the entire downscale-upscale process.
The second model used in these problems was a 3D ResNet-18 [114]
that is considerably more complex than 3D U-Net as can be seen in Table
4.1. However, the complexity does not guarantee better learning due to
the considerable difference between architectures and different types of
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Table 4.1. Comparison of the number of parameters of different models
Code Model name Parameters
U 3D U-Net 19,069,955 [28]
R 3D ResNet-18 32,990,000 [29]
connections. The construction of this model is based on building blocks,
and in this thesis, the original model was slightly adapted to work with
the dimensions of the input.
Conv, 33, F
BN
ReLU
Conv, 33, F
BN
ReLU
Conv, 33, F
BN
ReLU
Conv, 33, F
BN
ReLU
Conv, 33, 2F
BN
ReLU
Conv, 33, 2F
BN
ReLU
Figure 4.6. Adapted architecture of the basic block for three dimensional residual con-
volutional neural networks (3DResNet)[114]. This block is composed by the
following components: BN as Batch Normalization; ReLU as the Rectified
Linear Unit nonlinearity; and Conv, X3, F as a convolution with a kernel of
size X across the three dimensions and that maps the input to an output with
F channels. Basic block on the left is the Block A while the one on the right is
Block B.
The adapted building blocks, seen in Figure 4.6, differently from the
original version have a stride of size one, removing the downsampling
properties of these layers. These building blocks have three convolutional
layers each followed by a batch normalization layer and a ReLU activation.
The difference between both blocks is that the block on the left (Block
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A) does not change the number of channels, whereas Block B doubles
the number of channels in the first convolution. Moreover, both versions
include a shortcut residual connection between the output of the first
convolutional layer and the output of the third convolutional layer.
Conv, 73, 1, 3, 64
MaxPool, 33, 2, 1
Basic Block A, 1, 64
Basic Block B, 1, 128
Basic Block B, 1, 256
Basic Block B, 1, 512
UpConv, 23, 2, 32
Conv, 33, 1, 1, 32
Conv, 13, 1, 0, 1
Figure 4.7. Adapted architecture of a 3DResNet-18 [115] from the MedicalNet project,
which trained several three dimensional neural networks in a combined
dataset of various organs [29]. The weights of the network are available and
any adaptation of the network did not affect the original parameters.
The complete architecture is seen in Figure 4.7. It is composed of several
instances of the basic blocks, as well as other layers. The networks start
by convolving the input with a 7x7x7 kernel and mapping one channel
to 64. The following max-pooling layer downsamples to half the size and
then feeds it to a sequence of four basic blocks, with the first being of type
A and the following of type B. The original size is then restored by an
up-convolution and processed by two more convolutional layers. The final
output has one channel subject to sigmoid at each pixel. The network used
was already pretrained in another dataset for other organs [29] and the
weights were used as initial weights of this model.
47
Methods
4.2.3 Data augmentations
Neither the prostate cancer lesion segmentation problem nor the prostate
segmentation problem had abundant data and examples to learn from. As
seen before, machine learning and especially deep learning algorithms rely
considerably on the number of samples in the training set that represent
potentially different situations and variability between samples. Moreover,
variability in the data and a considerable number of distinct samples
is a mechanism to avoid also overfitting and improve the generalization
capabilities of the model at hand.
Figure 4.8. Example of a elastic deformation augmentation applied to a T2W image. The
original image is represented in the top left corner and the other are generated
by deformations with a spline order of 3, an alpha of 1000, and a sigma of
40. The deformations are applied to the whole 3D, however, in this image
only results in slice 13 are shown. This T2W sequence is from the IMPROD
dataset.
In Figure 4.8 it is shown an example of elastic deformation, that was
one of the augmentations used. The application of this transformation
to the image and to the mask increases the variability of the data by
giving slightly different shapes and sizes to the prostate cancer lesions.
Other transformations were also applied, such as random contrast, random
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Poisson noise, random Gaussian noise, and random rotations.
4.2.4 Prostate segmentation
The main goal of this problem is to predict the segmentation mask of the
prostate from multi-parametric magnetic resonance images. This problem
can be seen from two perspectives, first, it was attempted to achieve an
overlapping between the ground truth and the predicted mask. And it
can also be seen as the attempt to classify individually each pixel with a
positive or negative label.
Due to being present and visible in a considerable number of slices in
each MRI, and also to the fact that the prostate occupies a considerable
part of the slice when visible, the number of positive labels is abundant.
Moreover, size and shape variations between patient prostates exist, but
they are small and possible to learn by the model. The problem is, therefore,
simpler than other versions, for example, lesion classification, and requires
less tuning to attain the expected results.
This problem was used as a baseline for the models, a test to the per-
formance of the model, and the entire pipeline process that led to the
segmentation. The performance was evaluated in different sequences,
variable resampling sizes, and data augmentation in order to gather de-
tails regarding the ability to solve this problem and the impact of these
hyperparameters.
4.2.5 Lesions segmentation
Predicting a mask for prostate cancer lesion in multi-parametric magnetic
resonance images is a problem considerably more difficult than the seg-
mentation of the prostate. First, a lesion appears in fewer slices than the
prostate and that combined with the smaller size the lesions results in
much less positive pixels. Moreover, lesions are not mainly centered on
the magnetic resonance image, and not only their position varies, but the
shape and the slices where the lesion is visible vary too. Finally, the num-
ber of lesions to be segmented vary between patients, and this increases
the difficulty of the problem. This is also a far more difficult problem to
humans than just segmenting the prostate.
Each patient might have several lesions, thus it will also have several
masks, one for each prostate cancer lesion. The model, independently
of which architecture is used, do not try to identify individual lesions.
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Instead, the model tries to segment all lesion voxels present in one mp-
MRI. Therefore, it is necessary to create a mask composed by the union of
all the individual lesion masks of a patient. Thus, to combine the masks,
since the lesions do not overlap, a sum of all the masks is performed.
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5. Experiments and Results
Once the methods are established, it is time to conduct several research
experiments within the problem to be solved regarding the methods and the
data. Experiments help to understand which techniques work and which
ones do not work. Moreover, careful experimentation can improve already
working models. For example, the data to be used in one experiment can
be resized, the cropping can be performed differently, and the magnitude of
data augmentations can be increased or decreased. Slight changes in any of
these can have a considerable impact on the results, thus the experiments
must be conducted thoroughly.
In spite of not being the only indicator of good research, results are
crucial, and they should be a relevant part of any research. Frequently
results are compared to different research projects due to the use of the
same public dataset, however, since this thesis uses a private dataset,
the results are compared between several different experiments, with
considerable parameters changed between experiments.
In this chapter, the process used to conduct experiments is explored, the
results for each experiment are given and results are carefully detailed
and compared. Furthermore, an analysis of the methods is conducted, and
the reasons for the different performance results are discussed with the
advantages and disadvantages of the methods for each one of the problems
presented initially in this thesis. Finally, some of the experiments are
illustrated with visual examples of their performance, either using plots or
segmentation masks side by side.
5.1 Evaluation
Deep learning problem evaluation is usually performed in unseen data, in
order to also assess the capabilities of generalization from a specific model.
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In other words, if the model is overfitted to the training data. Splitting
the dataset to construct a test set can be done with different ratios, such
as 20%/80% or 25%/75%. However, the performance of the algorithm is
frequently biased by the selected split, and results can appear to be better
or worse depending on the data present in each set. In this problem a
cross-validation technique with five different folds is used.
Fold 1
Fold 2
Fold 3
Fold 4
Fold 5
Figure 5.1. Structure of the five folds. Each rectangle represents a subset of the dataset
containing 20% of the data. Green rectangles indicate that the data contained
is part of the training set. On the other hand the red rectangle indicate that
the data is used to test and evaluate the model.
The construction of the folds can be seen in Image 5.1, with each rectangle
corresponding to 20% of the data present in the dataset. To accurately
analyze the performance in a problem, a model is trained for each fold on
the 80% training data (green rectangles) and tested afterward on the data
present in the red rectangle of each fold. Finally, the results of all folds
are averaged. It is also important to note that this technique works with
different performance metrics, the data present in one rectangle is the
same in all the folds and the split is performed patient-wise.
5.2 Lesion classification
Experiments on the classification of lesions are conducted independently
for both problems with different losses, models, and metrics. However,
some elements are common to experiments in both problems. Both work
with two-dimensional images of lesions cropped from the slice where the
approximated area of the lesion is bigger. The cropping of this lesion can
be performed with a bounding box with a fixed size centered in the center
of the lesion or an adjustable bounding box that resizes to have the exact
size of the lesion that is resized afterward to the desired size. The cropping
is performed at 64 and 32 pixels (with an adjusted bounding box the lesion
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is resized to have this dimension), while the model receives a 56x56 and
28x28 image respectively. Moreover, the augmentations applied were the
same in both experiments with the images being subject to the following
random operations: crop with the size of the input of the model, horizontal
flip, vertical flip, and an affine transformation with 15 degrees of rotation,
a scaling between 0.50 and 1.50, a shear of 15, and translations of at most
0.07 in each direction. Whenever data augmentations are not used, the
image is simply centrally cropped to the size of the input of the model.
5.2.1 Clinical significance classification
To perform binary classification of prostate cancer lesion experiments, it
was necessary to define some configurations for the experiments, in other
words, a specific combination of techniques that can be applied in several
experiments. The experiments can vary in the type of cropping technique
to be used, the sizes of the cropping and the input size also vary, as well as
if data augmentations are used or not. Since all three of these parameters
have two different options each it results in 23 = 8 different configurations
to be used and evaluated.
Table 5.1. Different configurations of the experiments. Includes details of the cropping
technique used, if data augmentation techniques were used and what were the
values used for cropping the lesions and the input size for the model.
Config. Crop Size Input Size Crop Type Augmentations
A 64 56 Adjusted Box No
B 64 56 Adjusted Box Yes
C 64 56 Fixed Box No
D 64 56 Fixed Box Yes
E 32 28 Adjusted Box No
F 32 28 Adjusted Box Yes
G 32 28 Fixed Box No
H 32 28 Fixed Box Yes
The impact of the parameters is further analyzed individually in order
to understand not only which combinations work, and which do not, but
also to understand the independent impact of the parameter. Table 5.1
shows the eight different configurations. Each configuration is associated
with a letter, and it will be referred through that letter during the rest of
this section. All the experiments’ configurations described in the initial
phase of the experiment, before retrieving the lesions, resample the MRI
to 224x224 while keeping the original number of slices. An analysis of the
effect of the resampling was also conducted and the results discussed.
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Cropping the lesions
The impact of the cropping technique in the performance of the model
was not clear, therefore, some experiments comparing both techniques
described in this thesis were conducted.
Table 5.2. Comparison of the performance of the experiments using different sequences
types that used distinct sizes and different cropping techniques. For this
comparison all the selected experiments configurations do not include data
augmentations. Bold represents the best performance configuration in that
sequence type. All the values in this table represent AUC scores that were
computed in a cross-validation setup for each of the five folds, and averaged
across them.
Config. ADC T2W ADC+T2W Average
A 0.863 0.730 0.839 0.811
C 0.737 0.592 0.701 0.677
E 0.856 0.776 0.844 0.825
G 0.762 0.706 0.760 0.742
Table 5.2 illustrates the results of each experiment by the sequence
used as input of the model. It is possible to observe that configurations,
which crop the lesion with a bounding box adjusted to the lesion size
and resized afterward to the crop size, show better results regardless of
this size (A and E). Both these experiments demonstrated considerable
performance gains when compared to the use of a bounding box with a fixed
size. Moreover, despite the slightly better performance of configuration
A with ADC sequences when compared to the configuration E, the latter
displays substantially better results with T2W and with the combination
of both sequences, averaging also in a better AUC for the three different
inputs. Regarding the other configurations, G is by far superior to C in all
the inputs. Thus, it is possible to infer that a crop size of 32 with an input
size of 28 further improves the performance regardless of the cropping
technique used.
Data augmentation
Similarly to the cropping, the effect of data augmentations in the per-
formance of the model was also analyzed. The experiments to study its
impacts were divided into two different groups in order to establish a fair
comparison between configurations since, as seen before, the cropping
type impacts the performance. Therefore, the cropping technique was the
criterion to divide configurations into groups.
Table 5.3 displays the results for the experiments that used the best
performing cropping technique. Differently from what was expected, the
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Table 5.3. Analysis of the effects of data augmentation techniques in experiments that
used an adjusted box as cropping technique. Bold represents the best perfor-
mance configuration in that sequence type. All the values in this table represent
AUC scores that were computed in a cross-validation setup for each of the five
folds, and averaged across them.
Config. ADC T2W ADC+T2W Average
A 0.863 0.730 0.839 0.811
B 0.840 0.772 0.830 0.814
E 0.856 0.776 0.844 0.825
F 0.855 0.815 0.828 0.833
data augmentations do not seem to positively impact all the different
sequences used as input. For instance, on ADC sequences, the impact
seems to be negative, and while it can be neglected when comparing E and
F, it is somewhat larger when comparing A and B. In contrast, using T2W
sequences as the input seems to greatly impact the results in a positive
manner and this can be observed by direct comparison of A with B and
E with F which show improvements of approximately 0.04. However,
when combining both sequences, the impact is clearly negative in all the
experiments analyzed. In spite of having some negative impact, data
augmentations have improved the average AUC of a configuration when
compared to a similar one without data augmentations.
Table 5.4. Analysis of the effects of data augmentation techniques in experiments that
used a fixed box as cropping technique. Bold represents the best performance
configuration in that sequence type. All the values in this table represent AUC
scores that were computed in a cross-validation setup for each of the five folds,
and averaged across them.
Config. ADC T2W ADC+T2W Average
C 0.737 0.592 0.701 0.677
D 0.725 0.679 0.749 0.718
G 0.762 0.706 0.760 0.742
H 0.818 0.640 0.757 0.738
The impact of data augmentations on the experiments with different
cropping techniques is also different and distinct as seen in Table 5.4.
Furthermore, the impact also seems to be based on the cropping and
input sizes used. For instance, on larger sizes (C and D) the impact on
ADC seems to be negative with T2W and the combination of sequences
benefiting greatly from the augmentations. Whereas on smaller crop sizes
(G and H), ADC has a positive impact when using augmentations while the
other two different inputs have a decreased performance. It is also worth
noting that different from the results in Table 5.3, the augmentations do
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not improve the average AUC of all the configurations, instead, it decreases
the area under the curve in smaller input sizes.
Resampling
All the previous experiment configurations started by resampling the
magnetic resonance images to a 224x224 dimension while keeping the
number of slices untouched. However, this resampling undoubtedly affects
the performance, either negatively or positively. In order to properly assess
this impact, all the previous experiments were replicated without the
initial resampling and the results compared. Since in the previous section
it was shown that both data augmentations and the cropping technique
impact the results, the comparisons were performed between examples
that had these parameters in comparison, while the size of the crop and
the input size were the only variants within a results table.
Table 5.5. Comparison of the performance of the model if no resampling for 224x224 is
used, between configurations that use no augmentations and use a fixed box
crop technique. Bold represents the best performance configuration in that
sequence type. All the values in this table represent AUC scores that were
computed in a cross-validation setup for each of the five folds, and averaged
across them. WR stands for "With Resampling" whereas NR stands for "No
Resampling"
Config. ADC T2W ADC+T2W Average
C - WR 0.737 0.592 0.701 0.677
C - NR 0.620 0.627 0.676 0.641
G - WR 0.762 0.706 0.760 0.742
G - NR 0.631 0.656 0.655 0.647
Table 5.6 shows the results of the configuration with a fixed box with
worse performance, C, and the one with the best performance, G. Neither
include data augmentations, and the size of their crop varies with G
having the smaller value. In these cases, not resampling the images hurt
the average AUC score, especially of ADC sequences. This, however, can
be explained with the fact that the original size of ADC sequences is
rather small, thereby the lesions are also small, meaning that it may be
difficult to spot. On the other hand, while T2W performance decreased on
configuration G, it improved on C. The reason behind this is the fact that
the original size of T2W is considerably larger than the resampling size,
meaning that a larger crop size might better capture the lesions while a
small one might crop important parts of lesions.
Analyzing Table 5.6 where the results of two configurations with an
adjusted box and no augmentations are shown, A and E, it is possible to
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Table 5.6. Comparison of the performance of the model if no resampling for 224x224 is
used, between configurations that use no augmentations and use a adjusted
box crop technique. Bold represents the best performance configuration in that
sequence type. All the values in this table represent AUC scores that were
computed in a cross-validation setup for each of the five folds, and averaged
across them. WR stands for "With Resampling" whereas NR stands for "No
Resampling"
Config. ADC T2W ADC+T2W Average
A - WR 0.863 0.730 0.839 0.811
A - NR 0.834 0.741 0.818 0.798
E - WR 0.856 0.776 0.844 0.825
E - NR 0.870 0.750 0.818 0.813
observe similar patterns with lower average scores on experiments without
resampling, and improved results on the experiment with larger crop size
without resampling. However, in configuration E, the results for ADC show
an improvement to 0.87, which means that this configuration is the best
performing.
Table 5.7. Comparison of the performance of the model if no resampling for 224x224 is
used, between configurations that have data augmentations and use a adjusted
box crop technique. Bold represents the best performance configuration in that
sequence type. All the values in this table represent AUC scores that were
computed in a cross-validation setup for each of the five folds, and averaged
across them. WR stands for "With Resampling" whereas NR stands for "No
Resampling"
Config. ADC T2W ADC+T2W Average
B - WR 0.840 0.772 0.830 0.814
B - NR 0.839 0.825 0.830 0.831
F - WR 0.855 0.815 0.828 0.833
F - NR 0.820 0.803 0.814 0.812
Finally, Table 5.7 shows a comparison of the equivalent configurations
shown in Table 5.6 but with data augmentations. One interesting observa-
tion from this table is that the experiment B without resampling attains a
performance boost that allows it to outperform in the average AUC column
all the other configurations besides F with resampling. This happens due
to a major improvement in the performance using T2W sequences, that is
in a majority of the experiments below 0.80, and achieves a higher maxi-
mum with this configuration. This also allows configuration B to be the
only experiment to have a better performance without resampling than
with resampling. Arguably, this can be associated with the combination of
data augmentations that attenuated the degradation of the performance of
ADC sequences and further improved the performance of T2W sequences.
For each fold used in the cross-validation, a Receiver operating charac-
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Figure 5.2. Receiver operating characteristic (ROC) curve of the best performing model
for some selected folds out of the five folds present in the problem. Folds are
respectively from top to bottom numerated as 1, 3 and 4.
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teristic (ROC) curve was generated and the AUC for that fold calculated.
In Figure 5.2, it is possible to see these curves for some of the folds of the
experiment configuration E without the resampling on ADC sequences.
This was the configuration to achieve the best AUC score overall when
used on ADC sequences. The folds represented in the image are the folds
1, 3, and 4. These were selected because fold 1 is, alongside with following
2 and 5, the best performing fold, while 3 and 4 are the worst performing.
Despite having an inferior performance, fold 3 is close to the performance
of the others, whereas fold 4 is distant by 0.16. Moreover, the latter fold
has performed poorly in all the configurations, in some cases being below
0.60.
Figure 5.3. Comparison of the AUC score with the variation of the input size from a
adjusted box crop with a size of 64. The results are shown for four different
input sizes: 32, 40, 48 and 56. Although the selected size for performance
comparison is 56, it is possible to see that some sizes show better performance,
and that the selected size leads to a decreased performance of the T2W with
resampling. The letter R in front of the sequence means that before cropping
the lesion was resampled.
The final experiments regarding the binary classification of lesions were
conducted to analyze variation in the performance of experiments with a
crop size of 64 over different input sizes as seen in Figure 5.3. No data
augmentations were used, and the crop was performed by adjusting the
bounding box to the size of the lesion. Evaluations were performed in each
of the three different input types (ADC, T2W, and ADC+T2W), with and
without resampling for the following input sizes: 32, 40, 48, and 56. The
results are interesting, and while it is impossible to find a common input
size that maximizes the AUC in every experiment, it is possible to infer
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that 32 is an ineffective size overall. Moreover, all the experiments using
T2W, either alone or combined with ADC, have a peak in performance
when using an input of 40. The performance does not suffer significant
variations when the selected size is greater or equal to 40 in most of the
experiments, however, the experiment using T2W sequences as input with
resampling suffered a considerable degradation in performance with larger
input sizes.
5.2.2 PI-RADS classification
For the classification of the lesions accordingly with their PIRADS score,
six different experiments were performed to assess the performance of the
model in this problem. Before the experiments, it was also verified that
only one of the lesions that included mask had a PIRADS score below 3. It
was problematic and difficult to assess if the model can perform and learn
how to predict the score of lesions with low scores. This also increased the
difficulty of the training and the optimization of the model for the existent
lesions. Results for these experiments are given in terms of accuracy and
confusion matrices. Since in this problem the classes are not independent
and can be ordered in terms of proximity to each other, these matrices were
constructed to indicate if the target class was missed by one or two classes.
Moreover, the performance was also verified if the results aggregated both
scores 4 and 5.
Table 5.8. Table with the results of the accuracy of the experiments for all the input
sequences and with or without data augmentations. Bold highlights the best
performance column-wise. This results were calculated for separated scores 4
and 5. All the values in this table represent AUC scores that were computed in
a cross-validation setup for each of the five folds, and averaged across them.
Augmentations ADC T2W ADC+T2W Average
No 0.631 0.658 0.644 0.644
Yes 0.644 0.664 0.651 0.653
The first evaluation of the results was performed across all the five
different PIRADS scores. The results are shown in Table 5.8 and it is
also possible to analyze the impact of data augmentations. And despite
the improvements provided by those, the results are below what was
expected. This can be explained based on the skewness of the dataset that
does not include any sample for lesions with a score of 2, and only one
lesion has as a score of 1. Differently from what was seen in the previous
classification problem, the performance of using T2W as input is superior
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to the performance of using only ADC or combining both.
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Figure 5.4. Confusion matrix for experiments to predict the PIRADS score using resam-
pling, adjusted box cropping with a size of 32 and 28 input size on T2W
sequences. Left image included data augmentation and had an accuracy of
66.4% whereas the other did not included data augmentations with an accu-
racy of 64.8%. Green - Correct, Yellow - Missed by 1 class , Red - Missed by
more than one class
Figure 5.4 displays the results of Table 5.8 as confusion matrices. Both
images represent experiments that used T2W sequences as input, however,
the left image includes data augmentations, and as seen before a better
performance. It is also possible to observe that there is an overestimation
of lesions with a ground truth score of 3, being in a majority of the cases
classified as 4 or 5. As mentioned before, the skewness of the dataset is
most likely the reason for this overestimation.
Table 5.9. Table with the results of the accuracy of the experiments for all the input
sequences and with or without data augmentations. Bold highlights the best
performance column-wise. Results were calculated for classes 4 and 5 as a single
class. All the values in this table represent AUC scores that were computed in
a cross-validation setup for each of the five folds, and averaged across them.
Augmentations ADC T2W ADC+T2W Average
No 0.852 0.805 0.846 0.834
Yes 0.826 0.826 0.832 0.828
In order to explore the effects of this overestimation, scores 4 and 5 were
grouped in the final result. Not only overestimation, but also underestima-
tion is studied, however, with less impact. The results in Table 5.9 reflect
the impact of using this joint group which for both ADC and combined
sequences as the input changes the best performing model.
Despite the best results shown in Table 5.9, in Figure 5.5 it is possible to
observe a deficiency of the model in classifying lesions with a score of 3. In
the left image, 70% of lesions with label 3 are overestimated and 52% in
the right image. These high values represent the effect of the distribution
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Figure 5.5. Confusion matrix for experiments to predict the PIRADS score using resam-
pling, adjusted box cropping with a size of 32 and 28 input size without data
augmentations. Left image combined both T2W and ADC and had an accuracy
of 84.6% whereas the other did not included T2W sequences with an accuracy
of 85.2%. Green - Correct, Yellow - Missed by 1 class , Red - Missed by more
than one class
of the dataset in the results.
5.3 Detection and segmentation
The experiments to detect and segment prostate cancer lesions and to
detect and segment the prostate were executed similarly. The same prepro-
cessing techniques, the same models, and the same resampling sizes were
all used in experiments for both problems. In this section the 3D U-Net
and the 3D ResNet-18 models are experimented with different input sizes
and data augmentations.
Table 5.10. Different configurations of the experiments. Includes the dimensions of the
input to the model as well as the loss function to be minimized while optimizing
the model.
Config. Size Loss Function
A 128x128x16 3D Dice
B 128x128x16 3D Dice+BCE
C 224x224x16 3D Dice
D 224x224x16 3D Dice+BCE
Table 5.10 lists the dimensions used and the input sizes for each configu-
ration. The first size 128x128x16 was selected because it is the original
size of ADC sequences regarding width and height. While 224x224x16
was used since the original width and height (360x360) of T2W sequences
was too large to even fit one batch of size one in the GPU memory (RTX
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2080ti 11 Gb). Models for these problems ran in parallel with two GPUs,
which means that half of the batch was run in one GPU while the other
half ran in the other. Moreover, the use of 16 slices is due to the archi-
tecture of the 3D U-Net model that reduces every dimension by half at
each downsample block. Furthermore, the loss function used in each con-
figuration varies also, with some configurations using exclusively a 3D
dice loss, whereas the others use a combination of this latter loss with
the binary cross-entropy loss applied pixel-wise. The evaluation of the
experiments was performed with the resized ground truth mask to the size
of the respective configuration.
5.3.1 Prostate segmentation
Regarding the process of segmenting the prostate, the experiments con-
ducted had their results compared based on the resampling size used,
based on the models and finally the impact of data augmentations was also
analyzed and carefully discussed. The experiments using 3D U-Net ran
considerably faster than the 3D ResNet-18 experiments. While the former
used a learning rate of 5 ∗ 10−4 the latter used a learning rate of 2 ∗ 10−4.
Both versions of the experiments ran for 200 epochs and used the Adam
optimizer with a weight decay of 10−4. Regarding the size of the batches
used, configurations A and B used a batch size of four while C and D used
two as batch size. This difference is due to GPU memory limitations.
Input size and loss function
Both the size of the input used to feed the model and the loss function
used to calculate the error and backpropagate it in order to optimize the
network are important factors in the performance of a model. Thus, before
comparing the models against each other, it is important to compare and
understand the effects of these parameters on the performance of each
model.
Table 5.11 shows the performance of the 3D U-Net for all four configu-
rations and the two different input sizes. It is possible to observe three
different patterns. First, the performance using T2W sequences is always
superior to the performance of using ADC sequences in the same config-
uration. Secondly, in configurations with the same loss, the performance
is always superior, for all the input sequences in the configuration with
a smaller input size. Finally, the performance improves when using a
combination of loss functions.
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Table 5.11. Experiments on the segmentation of the prostate using a 3D U-Net model
in the different configurations. All the values in this table represent DICE
scores that were computed in a cross-validation setup for each of the five folds,
and averaged across them. The average column represents the mean of both
sequences. Bold highlights the best performance column-wise.
Config. Model ADC T2W Average
A 3D U-Net 0.893 0.889 0.891
B 3D U-Net 0.898 0.911 0.905
C 3D U-Net 0.873 0.882 0.878
D 3D U-Net 0.893 0.908 0.901
Despite the improvements that the loss function brought to the 3D U-Net,
Table 5.12 shows that the same is not reflected in the 3D ResNet-18 model.
Not only is it difficult to analyze and detect any pattern, but also the use
of different losses seemed to have a residual impact on the performance
of the model. While having slightly more impact on ADC sequences, the
input size impact can also be neglected when T2W sequences are used.
Table 5.12. Experiments on the segmentation of the prostate using a 3D ResNet-18 as
model in the different configurations. All the values in this table represent
DICE scores that were computed in a cross-validation setup for each of the five
folds, and averaged across them. The average column represents the mean of
both sequences. Bold highlights the best performance column-wise.
Config. Model ADC T2W Average
A 3D ResNet-18 0.895 0.886 0.891
B 3D ResNet-18 0.888 0.886 0.887
C 3D ResNet-18 0.876 0.888 0.882
D 3D ResNet-18 0.872 0.891 0.882
Models
Comparison between models is also useful in order to understand how they
perform and in which conditions should a model be used. The comparison
of these models was only performed on configurations that had an input
size of 128x128x16, configurations A and B.
On Table 5.13 it is possible to observe that the performance of the models
varies, especially when a combination of loss functions is used. While
having a quite similar performance with the 3D dice loss, the 3D U-Net
outperforms the other model when the binary cross-entropy is also used.
These results are different from what would be expected considering the
complexity difference of both models. However, the particular U-shaped
architecture has shown to achieve slightly better results, and since it is
also faster to train, further experiments in the segmentation of the prostate
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Table 5.13. Comparison of the models 3D ResNet-18 and 3D U-Net in the configurations
A and B, the ones that gave better results overall in the segmentation of
the prostate. All the values in this table represent DICE scores that were
computed in a cross-validation setup for each of the five folds, and averaged
across them. The average column represents the mean of both sequences. Bold
highlights the best performance column-wise.
Config. Model ADC T2W Average
A 3D U-Net 0.893 0.889 0.891
A 3D ResNet-18 0.895 0.886 0.891
B 3D U-Net 0.898 0.911 0.905
B 3D ResNet-18 0.888 0.886 0.887
use the 3D U-Net as the model.
Data Augmentations
In an attempt to further improve the performance of the experiments, a
couple of variations of these were performed using data augmentation
techniques. The data augmentations used did not, however, have a high
magnitude, since it is important to restrain the distortions that may go
beyond the distribution of the data in the real-world.
Table 5.14. Analysis of the impact of data augmentation techniques in the performance of
the 3D U-Net model in the configurations A and B in segmenting the prostate.
All the values in this table represent DICE scores that were computed in a
cross-validation setup for each of the five folds, and averaged across them.
The average column represents the mean of both sequences. Bold highlights
the best performance column-wise.
Config. Model Augmentation ADC T2W Average
A 3D U-Net No 0.893 0.889 0.891
A 3D U-Net Yes 0.902 0.900 0.901
B 3D U-Net No 0.898 0.911 0.905
B 3D U-Net Yes 0.915 0.910 0.913
As expected, the use of these augmentations slightly improved the per-
formance of the model for both the loss functions used. The improvement
margin was similar in both cases, however, due to the initial better perfor-
mance of the combination of both losses, the use of augmentations in that
experiment improves the DICE score to a value of 0.915. Another partic-
ularity is that these new experiments show better performance in ADC
images when compared to T2W images, which is the opposite of previous
experiments.
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Final Results
Configuration B, including data augmentations and using a 3D U-Net as
the model, was the best experiment of this problem. Thus, the experiment
was selected to be analyzed fold-wise. Table 5.15 shows the performance
of the model on the different folds, and it is possible to observe that the
results do not vary significantly with fold 3 being the only one to be below
a 0.910 DICE score.
Table 5.15. Performance in each fold of the model that performed the best in each sequence
in the table 5.14. All the values in this table represent DICE scores . The
average column represents the mean of both sequences. Bold highlights the
best performance column-wise.
Fold ADC T2W Average
1 0.9182 0.9164 0.9173
2 0.9136 0.9113 0.9125
3 0.9086 0.9023 0.9055
4 0.9146 0.9103 0.9125
5 0.9188 0.9116 0.9152
The results in this problem indicate that the segmentation is being
performed with significant quality and the visualizations of the predictions
are also similar to the visualizations of the ground truth. Figure 5.6 shows
predictions for consecutive slices in the fold 5 of this experiment using
ADC sequences as input.
Figure 5.6. Sample predictions made by a 3D U-Net model from the fold 5 of experiment
configuration B with data augmentations using ADC as input. Images repre-
sent slices with mask predictions on the same patient compared to the ground
truth. Left side of each image contains the prediction whereas the right size
contains the label.
Table 5.16 shows a comparison between the methods presented in this
paper and other methods presented in literature. It is important to note
that this is not an objective comparison of methods, since a different
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dataset was used. However, these results denote that despite performing
in different dataset, the presented method achieves and perhaps surpasses
the expected performance.
Table 5.16. Comparison of the results presented in other papers that attempted to ap-
proach prostate segmentation with deep learning methods. Bold highlights
the best performance column-wise. All the values in this table represent DICE
scores.
Method ADC T2W ADC+T2W Best
Ours 0.92 0.91 - 0.92
[113] 0.86 0.86 0.88 0.88
[111] - 0.85 - 0.85
[110] - 0.91 - 0.91
[112] - - 0.87 0.87
5.3.2 Lesion segmentation
The segmentation of prostate cancer lesions had similar experiments to
the previous problem regarding the segmentation of the prostate. Similar
analyses were conducted on the input size, data augmentations, and differ-
ent models. Despite these similarities that also include the same Adam
optimizer, the same weight decay value of 10−4 and the same batch size
for the different configurations (A and B have a batch size of four while C
and D have a batch size of two in order to fit in the GPU) there are some
differences. Due to being a slightly more complicated problem, the models
trained for 250 epochs in this problem, and the learning rates were 2 ∗ 10−4
for the 3D U-Net Model and 7 ∗ 10−5 for the 3D ResNet-18 model. The
results in the experiments regarding this problem reflect the difficulty of
the task at hand.
Input size and loss function
Studying the loss function and the input size that optimizes the results
of each model is important in order to understand the limitations of the
model and how they can be explored.
An increase in the size of the input dramatically increases the time
needed in the backward and forward pass of the training, and also the
inference time. Therefore, increased training and inference can only be jus-
tified if these larger sizes represent significant performance improvements.
Table 5.17 illustrates the results for the experiments using a 3D U-Net
model. It is possible to observe two patterns in the table. Firstly, once more,
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Table 5.17. Experiments on the segmentation of the prostate cancer lesions using a 3D
U-Net as model in the different configurations. All the values in this table
represent DICE scores that were computed in a cross-validation setup for each
of the five folds, and averaged across them. The average column represents the
mean of both sequences. Bold highlights the best performance column-wise.
Config. Model ADC T2W Average
A 3D U-Net 0.500 0.500 0.500
B 3D U-Net 0.674 0.530 0.602
C 3D U-Net 0.630 0.511 0.571
D 3D U-Net 0.652 0.516 0.584
when no data augmentations are being used, the combination of 3D dice
loss and binary cross-entropy shows significant improvements regardless
of the sequence given as input or the size of the sequence. Secondly, the
performance of ADC sequences is usually superior to the performance
of T2W sequences, and in most cases, there is a considerable difference
between the performance of both.
Table 5.18. Experiments on the segmentation of prostate cancer lesions using a 3D ResNet-
18 as model in the different configurations. All the values in this table repre-
sent DICE scores that were computed in a cross-validation setup for each of
the five folds, and averaged across them. The average column represents the
mean of both sequences. Bold highlights the best performance column-wise.
Config. Model ADC T2W Average
A 3D ResNet-18 0.500 0.385 0.443
B 3D ResNet-18 0.501 0.438 0.470
C 3D ResNet-18 0.500 0.501 0.501
D 3D ResNet-18 0.500 0.503 0.502
The results observed in Table 5.18 are rather poor. Despite the slight
performance increase on T2W sequences when the size is increased, neither
3D dice nor the combined loss seem to be enough to optimize the model.
Smaller sizes show a performance degradation of T2W sequences, thus an
inferior performance compared to the ADC sequences.
Models
Differently from what was seen in the prostate segmentation problem, the
models show a completely distinct performance when compared against
each other.
Table 5.19 displays the values for these experiments, and it is possible
to observe that not only the performance of the 3D ResNet-18 model does
not go beyond 0.501, but it gets near that value with ADC sequences since
T2W performs always poorly. The results of the best 3D U-Net model are
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Table 5.19. Comparison of the models 3D ResNet-18 and 3D U-Net in the configurations A
and B, the ones that gave better results overall in the segmentation of prostate
cancer lesions. All the values in this table represent DICE scores that were
computed in a cross-validation setup for each of the five folds, and averaged
across them. The average column represents the mean of both sequences. Bold
highlights the best performance column-wise.
Config. Model ADC T2W Average
A 3D U-Net 0.500 0.500 0.500
A 3D ResNet-18 0.500 0.385 0.443
B 3D U-Net 0.674 0.530 0.602
B 3D ResNet-18 0.501 0.438 0.470
34.5% and 21.0% higher for ADC and T2W sequences respectively when
compared to the other model in the same configuration. Once more the
performance of the 3D U-Net model outperforms the 3D ResNet-18, this
time by a significant margin. Further experiments use the 3D U-Net as
the model.
Data Augmentations
Data augmentation will once more be used to see how much further the per-
formance of the model can be improved. The previous two best-performing
experiments in the comparison of the models were used in two new experi-
ments that included data augmentations in the Data loading stage.
Table 5.20. Analysis of the impact of data augmentation techniques in the performance of
the 3D U-Net model in the configurations A and B to segment prostate cancer
lesions. All the values in this table represent DICE scores that were computed
in a cross-validation setup for each of the five folds, and averaged across them.
The average column represents the mean of both sequences. Bold highlights
the best performance column-wise.
Config. Model Augmentation ADC T2W Average
A 3D U-Net No 0.500 0.500 0.500
A 3D U-Net Yes 0.690 0.491 0.591
B 3D U-Net No 0.674 0.530 0.602
B 3D U-Net Yes 0.681 0.526 0.604
The impact of the augmentations in the performance of the model did
not seem to be positive when T2W sequences were given as input with
results slightly worse than the ones without data augmentations. However,
the performance in ADC sequences greatly benefited from the inclusion
of such transformations. Observing the data presented in Table 5.20,
it is possible to observe a small 1% improvement when ADC sequences
were given to a model optimized with the combined loss function, yet the
performance of this model was already far superior to previous models
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without data augmentations. The largest performance boost is with the
use of the 3D dice and ADC sequences, where the augmentations help the
model to achieve a performance 38% higher when compared to the model
without augmentations. This new value is the best DICE score in all the
experiments.
Final Results
Using data augmentation in configuration A gave the best results for ADC
inputs, while for T2W, configuration B without augmentations had the best
results. Both these experiments can be seen in Table 5.21 with the results
in each fold discriminated.
Table 5.21. Performance in each fold of the model that performed the best in each sequence
in the table 5.20. All the values in this table represent DICE scores. The
average column represents the mean of both sequences. Bold highlights the
best performance column-wise.
Fold ADC T2W Average
1 0.4686 0.2964 0.3825
2 0.6722 0.5214 0.5968
3 0.7003 0.5832 0.6418
4 0.8302 0.6564 0.7433
5 0.7896 0.6005 0.6951
It is important to note that the performance varies significantly between
folds, especially between folds 1 and 4 with the latter having 77.1% and
121.5% higher performance in ADC and T2W sequences respectively when
compared to the performance of the former. It is also worth noting that
while T2W results are relatively poorer, the variation fold-wise is similar
to the variation that occurs with ADC sequences. The best performing fold
for ADC sequences displays somewhat promising results.
Figure 5.7 displays some predictions given of the model for the fold 4
of ADC sequences. The predictions have some distance from the ground
truth, either by being smaller, having a somewhat more simplistic shape,
or simply by appearing one or two slices before expected.
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Figure 5.7. Sample predictions made by a 3D U-Net model from the fold 4 of experiment
configuration A with data augmentations using ADC as input. Images repre-
sent slices with mask predictions on the same patient compared to the ground
truth. Left side of each image contains the prediction whereas the right size
contains the label.
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6. Conclusion and Future Work
This research approached deep learning methods for prostate cancer di-
agnosis problems based on multi-parametric magnetic resonance images.
From the information contained in these images, the purpose was to under-
stand which problems could be solved or addressed using computer vision
methods and deep learning. Some of the problems required lesions to be
classified. Others required the prostate or prostate cancer lesions to be
detected in the MRI and segmented accordingly to the annotations given
by experts.
Deep learning approaches dwell in a world that is unreachable for some
domains, the world of big data and massive volumes of information. This is,
for now, the case of medical use cases. The information is very limited, not
only due to the requirements of experts, but also due to privacy matters.
Hence, it was a challenge that required a thorough analysis of the problem,
the preprocessing techniques, the models and the hyperparameters to use.
Overall, a deep analysis of the performance of each problem was conducted
and the results discussed.
The image quality and the annotations carefully made by experts sup-
ported the learning process of the model. However, other characteristics
were considerably less positive. First of all, the small number of samples
hurt the performance. Secondly, the distribution of the PIRADS score of
lesions with mask increased the difficulty of the problem. Moreover, the
overall number of patients was rather small. This affected the performance
in some tasks, such as the segmentation of lesions. The latter task due
to its nature requires significantly more data in order to achieve better
results.
Regarding the classification of lesions, the performance varied greatly
between tasks. Results in the cross-validation score presented in Section
5.2.1 for the clinical significance of lesions were superior to the 0.84 AUC
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obtained by XmasNet in the ProstateX challenge [27]. This while using
fewer sequences as input, thus also using fewer parameters [27]. And
while the challenge dataset had poor data quality, the number of images,
from the 346 patients, was considerably higher. Hence, the results not
only matched the expectations, but they can also be considered promising.
It is expected that if the number of samples increases while keeping the
quality of the data, the performance may also increase. Despite these
results, the distribution of the PIRADS score from lesion with masks did
not allow the performance in this task to be the expected. The performance
was significantly worse than the binary classification and was not nearly
enough to be adopted in a clinical situation or the problem to be considered
solved.
The process of detecting those lesions and segment them is rather com-
plicated. Thus, in order to test and validate the research methodology to
be followed, one experiment was conducted before segmenting lesions. The
extra prostate mask annotations given in the dataset were used to detect
and segment the prostate itself. The results shown in Section 5.3.1 ex-
ceeded expectations. Not only both the models perform as required on both
sizes and with both losses. But experiments were further improved with
data augmentation techniques. The results were not only promising, but
they also surpassed performance in previous research [110, 111, 112, 113].
Therefore, all the experiments were repeated for lesion segmentation, yet,
without achieving results close to the previous problem. The results indi-
cate, however, some promising details. Such as the performance increase in
the experiments that used data augmentations. These details may indicate
that increasing the data in the dataset is also crucial to improve upon the
0.69 DICE score obtained in this task. And while some folds performed
poorly, others presented results that achieved a DICE score up to 0.83.
Understanding the reason behind these distinct results might in the future
lead to gains in the performance. And despite the results in this task being
inferior to the ones in the previous segmentation task, it is important to
note that the results are somewhat slightly better than the ones presented
by previous researchers [112, 113].
The relevance of the work presented in this thesis goes beyond the sim-
ple analysis of the results. The thesis demonstrates that deep learning
methods can be applied to solve computer vision tasks on multi-parametric
magnetic resonance images regarding the prostate cancer diagnosis. De-
spite only being able to achieve the desired results on two of the four
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tasks. The remaining tasks have shown a potential that can be achieved
by addressing some of the flaws regarding the data previously mentioned.
Further research is still needed to study other plausibly relevant ques-
tions. Studies on the performance of the model in classifications tasks can
be conducted by averaging the prediction of two models trained in different
sequences accordingly to different configurations. It can also be analyzed
if the Gleason score can be better predicted through this data compared
to the PIRADS score. Regarding the segmentation, the registration of
both sequences or the addition of more augmentations can be empirically
studied. All these future work is based on the results given in this thesis
that conducted and presented more than 112 different experiments. More
experiments were conducted in the background and were not presented in
the thesis but they were essential to tune the necessary hyperparameters
for the final experiments. The goals of the thesis were therefore achieved,
and the ground for future work on this dataset established.
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A. Prostate Segmentation
Figure 1.1. Sample predictions made by a 3D U-Net model from the fold 5 of experiment
configuration B with data augmentations using ADC as input. Images repre-
sent slices with mask predictions on the same patient compared to the ground
truth. Left side of each image contains the prediction whereas the right size
contains the label.
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Prostate Segmentation
Figure 1.2. Sample predictions made by a 3D U-Net model from the fold 5 of experiment
configuration B with data augmentations using ADC as input. Images repre-
sent slices with mask predictions on the same patient compared to the ground
truth. Left side of each image contains the prediction whereas the right size
contains the label.
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B. Lesions Segmentation
Figure 2.1. Sample predictions made by a 3D U-Net model from the fold 4 of experiment
configuration A with data augmentations using ADC as input. Images repre-
sent slices with mask predictions on the same patient compared to the ground
truth. Left side of each image contains the prediction whereas the right size
contains the label.
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Lesions Segmentation
Figure 2.2. Sample predictions made by a 3D U-Net model from the fold 4 of experiment
configuration A with data augmentations using ADC as input. Images repre-
sent slices with mask predictions on the same patient compared to the ground
truth. Left side of each image contains the prediction whereas the right size
contains the label.
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